Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | DDX41 | Human | Acute Erythroleukemia | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:30926971 | |
|
Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | DDX41 | Human | Acute Erythroleukemia | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:30926971 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
DDX41 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ddx41 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ddx41 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ddx41 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DDX41 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DDX41 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ddx41 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DDX41 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DDX41 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ddx41 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in DDX41
508 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_016222.4(DDX41):c.572-1G>A | single nucleotide variant | not provided [RCV000522122] | Chr5:177515259 [GRCh38] Chr5:176942260 [GRCh37] Chr5:5q35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176132340-177586960)x1 | copy number loss | See cases [RCV000050645] | Chr5:176132340..177586960 [GRCh38] Chr5:175559343..177013961 [GRCh37] Chr5:175491949..176946567 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q32-35.3(chr5:149714592-181272151)x3 | copy number gain | See cases [RCV000051863] | Chr5:149714592..181272151 [GRCh38] Chr5:149094155..180699152 [GRCh37] Chr5:149074348..180631758 [NCBI36] Chr5:5q32-35.3 |
pathogenic |
GRCh38/hg38 5q33.3-35.3(chr5:160029980-181269805)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051865]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051865]|See cases [RCV000051865] | Chr5:160029980..181269805 [GRCh38] Chr5:159456987..180696806 [GRCh37] Chr5:159389565..180629412 [NCBI36] Chr5:5q33.3-35.3 |
pathogenic |
GRCh38/hg38 5q34-35.3(chr5:168689326-181269946)x3 | copy number gain | See cases [RCV000051866] | Chr5:168689326..181269946 [GRCh38] Chr5:168116331..180696947 [GRCh37] Chr5:168048909..180629553 [NCBI36] Chr5:5q34-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:175851047-178365049)x3 | copy number gain | See cases [RCV000051867] | Chr5:175851047..178365049 [GRCh38] Chr5:175278050..177792050 [GRCh37] Chr5:175210656..177724656 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:175889986-180793986)x3 | copy number gain | See cases [RCV000051868] | Chr5:175889986..180793986 [GRCh38] Chr5:175316989..180220986 [GRCh37] Chr5:175249595..180153592 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:175007241-179089812)x1 | copy number loss | See cases [RCV000052151] | Chr5:175007241..179089812 [GRCh38] Chr5:174434244..178516813 [GRCh37] Chr5:174366850..178449419 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176043476-177995759)x1 | copy number loss | See cases [RCV000053127] | Chr5:176043476..177995759 [GRCh38] Chr5:175470479..177422760 [GRCh37] Chr5:175403085..177355366 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176115257-177646633)x1 | copy number loss | See cases [RCV000053128] | Chr5:176115257..177646633 [GRCh38] Chr5:175542260..177073634 [GRCh37] Chr5:175474866..177006240 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176152073-177986213)x1 | copy number loss | See cases [RCV000053129] | Chr5:176152073..177986213 [GRCh38] Chr5:175579076..177413214 [GRCh37] Chr5:175511682..177345820 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176152073-177646633)x1 | copy number loss | See cases [RCV000053131] | Chr5:176152073..177646633 [GRCh38] Chr5:175579076..177073634 [GRCh37] Chr5:175511682..177006240 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176149599-177716401)x3 | copy number gain | See cases [RCV000053481] | Chr5:176149599..177716401 [GRCh38] Chr5:175576602..177143402 [GRCh37] Chr5:175509208..177076008 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic|uncertain significance |
NM_016222.2(DDX41):c.1088C>A (p.Ser363Tyr) | single nucleotide variant | Malignant melanoma [RCV000066867] | Chr5:177513695 [GRCh38] Chr5:176940696 [GRCh37] Chr5:176873302 [NCBI36] Chr5:5q35.3 |
not provided |
NM_016222.4(DDX41):c.936-242G>A | single nucleotide variant | not provided [RCV001572103] | Chr5:177514089 [GRCh38] Chr5:176941090 [GRCh37] Chr5:5q35.3 |
likely benign |
GRCh38/hg38 5q33.3-35.3(chr5:156825512-181269805)x3 | copy number gain | See cases [RCV000133847] | Chr5:156825512..181269805 [GRCh38] Chr5:156252523..180696806 [GRCh37] Chr5:156185101..180629412 [NCBI36] Chr5:5q33.3-35.3 |
pathogenic |
GRCh38/hg38 5q34-35.3(chr5:164386701-181269805)x3 | copy number gain | See cases [RCV000135546] | Chr5:164386701..181269805 [GRCh38] Chr5:163813707..180696806 [GRCh37] Chr5:163746285..180629412 [NCBI36] Chr5:5q34-35.3 |
pathogenic |
GRCh38/hg38 5q35.3(chr5:177261458-177651722)x3 | copy number gain | See cases [RCV000138817] | Chr5:177261458..177651722 [GRCh38] Chr5:176688459..177078723 [GRCh37] Chr5:176621065..177011329 [NCBI36] Chr5:5q35.3 |
likely benign|uncertain significance |
GRCh38/hg38 5q35.1-35.3(chr5:169334755-181285301)x3 | copy number gain | See cases [RCV000141249] | Chr5:169334755..181285301 [GRCh38] Chr5:168761759..180712302 [GRCh37] Chr5:168694337..180644908 [NCBI36] Chr5:5q35.1-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:175536771-181292788)x1 | copy number loss | See cases [RCV000141987] | Chr5:175536771..181292788 [GRCh38] Chr5:174963774..180719789 [GRCh37] Chr5:174896380..180652395 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:175989092-178009412)x1 | copy number loss | See cases [RCV000142365] | Chr5:175989092..178009412 [GRCh38] Chr5:175416095..177436413 [GRCh37] Chr5:175348701..177369019 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176132340-177995759)x1 | copy number loss | See cases [RCV000142510] | Chr5:176132340..177995759 [GRCh38] Chr5:175559343..177422760 [GRCh37] Chr5:175491949..177355366 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176291838-178662699)x1 | copy number loss | See cases [RCV000142047] | Chr5:176291838..178662699 [GRCh38] Chr5:175718841..178089700 [GRCh37] Chr5:175651447..178022306 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176700128-181269805)x1 | copy number loss | See cases [RCV000142648] | Chr5:176700128..181269805 [GRCh38] Chr5:176127129..180696806 [GRCh37] Chr5:176059735..180629412 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176517339-177709289)x1 | copy number loss | See cases [RCV000142538] | Chr5:176517339..177709289 [GRCh38] Chr5:175944340..177136290 [GRCh37] Chr5:175876946..177068896 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
GRCh38/hg38 5q35.2-35.3(chr5:176143674-178009412)x1 | copy number loss | See cases [RCV000143463] | Chr5:176143674..178009412 [GRCh38] Chr5:175570677..177436413 [GRCh37] Chr5:175503283..177369019 [NCBI36] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.1293A>C (p.Thr431=) | single nucleotide variant | not specified [RCV000192583] | Chr5:177513020 [GRCh38] Chr5:176940021 [GRCh37] Chr5:5q35.3 |
likely benign |
GRCh37/hg19 5q35.2-35.3(chr5:174397487-180686444)x1 | copy number loss | See cases [RCV000167565] | Chr5:174397487..180686444 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer) | duplication | Acute myeloid leukemia [RCV000193600]|DDX41-related disorder [RCV004751355]|DDX41-related hematologic malignancy predisposition syndrome [RCV000210272]|not provided [RCV001008139] | Chr5:177515944..177515945 [GRCh38] Chr5:176942945..176942946 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|risk factor |
GRCh37/hg19 5q35.2-35.3(chr5:174990352-180690937) | copy number gain | not provided [RCV000767711] | Chr5:174990352..180690937 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.490C>T (p.Arg164Trp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV000210264]|not provided [RCV001818508] | Chr5:177515766 [GRCh38] Chr5:176942767 [GRCh37] Chr5:5q35.3 |
likely pathogenic|risk factor|conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.2(DDX41):c.415_419dupGATG | duplication | MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO [RCV000210272] | Chr5:5q35.3 | risk factor |
NM_016222.4(DDX41):c.435-2_435-1delinsCA | indel | DDX41-related hematologic malignancy predisposition syndrome [RCV000210273]|not provided [RCV001815218] | Chr5:177515822..177515823 [GRCh38] Chr5:176942823..176942824 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|risk factor |
NM_016222.4(DDX41):c.3G>A (p.Met1Ile) | single nucleotide variant | Bone marrow hypocellularity [RCV001256169]|DDX41-related disorder [RCV003907781]|DDX41-related hematologic malignancy predisposition syndrome [RCV000210251]|Myelodysplasia [RCV001256171]|not provided [RCV000519179] | Chr5:177516943 [GRCh38] Chr5:176943944 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|risk factor|uncertain significance |
NM_016222.4(DDX41):c.1187T>C (p.Ile396Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV000210262]|not provided [RCV001553497] | Chr5:177513396 [GRCh38] Chr5:176940397 [GRCh37] Chr5:5q35.3 |
likely pathogenic|risk factor |
NM_016222.4(DDX41):c.1574G>A (p.Arg525His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV000210250]|not provided [RCV002288840] | Chr5:177512369 [GRCh38] Chr5:176939370 [GRCh37] Chr5:5q35.3 |
pathogenic|risk factor|uncertain significance |
GRCh37/hg19 5q15-35.3(chr5:94844077-178830410)x3 | copy number gain | not provided [RCV000487658] | Chr5:94844077..178830410 [GRCh37] Chr5:5q15-35.3 |
likely benign |
NM_016222.4(DDX41):c.1A>C (p.Met1Leu) | single nucleotide variant | not provided [RCV002285999] | Chr5:177516945 [GRCh38] Chr5:176943946 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.121C>T (p.Gln41Ter) | single nucleotide variant | DDX41-related disorder [RCV003424157]|DDX41-related hematologic malignancy predisposition syndrome [RCV001764696]|not provided [RCV000579037] | Chr5:177516742 [GRCh38] Chr5:176943743 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|not provided |
Single allele | duplication | not provided [RCV000768450] | Chr5:175843728..180703728 [GRCh37] Chr5:5q35.2-35.3 |
likely pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:176274007-180719789)x1 | copy number loss | See cases [RCV000447018] | Chr5:176274007..180719789 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789) | copy number gain | See cases [RCV000510723] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175722788-177423091)x3 | copy number gain | See cases [RCV000445774] | Chr5:175722788..177423091 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:176505173-178230923)x1 | copy number loss | See cases [RCV000445817] | Chr5:176505173..178230923 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:174427052-180719789)x1 | copy number loss | See cases [RCV000448611] | Chr5:174427052..180719789 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q21.3-35.3(chr5:106716357-180687338)x3 | copy number gain | See cases [RCV000448245] | Chr5:106716357..180687338 [GRCh37] Chr5:5q21.3-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175601473-180100378)x1 | copy number loss | See cases [RCV000448793] | Chr5:175601473..180100378 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.1-35.3(chr5:171396359-180719789)x3 | copy number gain | See cases [RCV000448458] | Chr5:171396359..180719789 [GRCh37] Chr5:5q35.1-35.3 |
pathogenic |
NM_016222.4(DDX41):c.91G>A (p.Glu31Lys) | single nucleotide variant | not provided [RCV000482372] | Chr5:177516772 [GRCh38] Chr5:176943773 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.1-35.3(chr5:172031248-180719789)x3 | copy number gain | See cases [RCV000512068] | Chr5:172031248..180719789 [GRCh37] Chr5:5q35.1-35.3 |
pathogenic |
NM_016222.4(DDX41):c.1016G>A (p.Arg339His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004568632]|not provided [RCV002264947]|not specified [RCV000501123] | Chr5:177513767 [GRCh38] Chr5:176940768 [GRCh37] Chr5:5q35.3 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1233G>A (p.Glu411=) | single nucleotide variant | not provided [RCV001558404]|not specified [RCV000503645] | Chr5:177513080 [GRCh38] Chr5:176940081 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.232_233insAA (p.Pro78fs) | insertion | DDX41-related hematologic malignancy predisposition syndrome [RCV000503753]|not provided [RCV003565425] | Chr5:177516353..177516354 [GRCh38] Chr5:176943354..176943355 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.1665C>T (p.Ala555=) | single nucleotide variant | not provided [RCV003660808]|not specified [RCV000501533] | Chr5:177512163 [GRCh38] Chr5:176939164 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.*74C>T | single nucleotide variant | not provided [RCV001662492]|not specified [RCV000503769] | Chr5:177511717 [GRCh38] Chr5:176938718 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.1683C>T (p.Pro561=) | single nucleotide variant | not provided [RCV002527235]|not specified [RCV000499384] | Chr5:177512145 [GRCh38] Chr5:176939146 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1016G>T (p.Arg339Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV000504169] | Chr5:177513767 [GRCh38] Chr5:176940768 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1105C>G (p.Arg369Gly) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003470627]|not provided [RCV001770380]|not specified [RCV000502075] | Chr5:177513478 [GRCh38] Chr5:176940479 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+9G>A | single nucleotide variant | not provided [RCV003718247]|not specified [RCV000502282] | Chr5:177516910 [GRCh38] Chr5:176943911 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.323del (p.Lys108fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV000502578] | Chr5:177516169 [GRCh38] Chr5:176943170 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.139-4T>G | single nucleotide variant | DDX41-related disorder [RCV003979888]|Inborn genetic diseases [RCV004609412]|not provided [RCV002527236]|not specified [RCV000500186] | Chr5:177516451 [GRCh38] Chr5:176943452 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.1142dup (p.Ile382fs) | duplication | DDX41-related hematologic malignancy predisposition syndrome [RCV000500690] | Chr5:177513440..177513441 [GRCh38] Chr5:176940441..176940442 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.138+5G>T | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV002254700]|not provided [RCV001731724]|not specified [RCV000500915] | Chr5:177516720 [GRCh38] Chr5:176943721 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:175438045-177392885)x1 | copy number loss | See cases [RCV000511974] | Chr5:175438045..177392885 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)x3 | copy number gain | See cases [RCV000512039] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175570677-177439550)x3 | copy number gain | See cases [RCV000511393] | Chr5:175570677..177439550 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.3(DDX41):c.418_419insGATG (p.Asp140Glyfs) | insertion | Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to [RCV000496036] | Chr5:177515944..177515945 [GRCh38] Chr5:176942945..176942946 [GRCh37] Chr5:5q35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175570677-180719789)x1 | copy number loss | See cases [RCV000510785] | Chr5:175570677..180719789 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.571+3A>G | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466055]|not provided [RCV003318213] | Chr5:177515682 [GRCh38] Chr5:176942683 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1273_1276dup (p.Glu426fs) | duplication | not provided [RCV000627551] | Chr5:177513036..177513037 [GRCh38] Chr5:176940037..176940038 [GRCh37] Chr5:5q35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175570678-177437340)x1 | copy number loss | See cases [RCV000512405] | Chr5:175570678..177437340 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
Single allele | duplication | not provided [RCV000677989] | Chr5:176798338..177423150 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:175438045-177481250)x1 | copy number loss | not provided [RCV000682614] | Chr5:175438045..177481250 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175570677-177436413)x1 | copy number loss | not provided [RCV000682615] | Chr5:175570677..177436413 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.3(chr5:176918345-179061393)x1 | copy number loss | not provided [RCV000682619] | Chr5:176918345..179061393 [GRCh37] Chr5:5q35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:176044976-177023859)x1 | copy number loss | not provided [RCV000682618] | Chr5:176044976..177023859 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.649T>C (p.Ser217Pro) | single nucleotide variant | DDX41-related disorder [RCV003405712]|DDX41-related hematologic malignancy predisposition syndrome [RCV003470861]|not provided [RCV001548314] | Chr5:177515065 [GRCh38] Chr5:176942066 [GRCh37] Chr5:5q35.3 |
likely pathogenic|uncertain significance |
GRCh37/hg19 5p15.33-q35.3(chr5:13648-180905029)x3 | copy number gain | not provided [RCV000744317] | Chr5:13648..180905029 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:25328-180693344)x3 | copy number gain | not provided [RCV000744323] | Chr5:25328..180693344 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5q33.2-35.3(chr5:155344802-180693344)x3 | copy number gain | not provided [RCV000745284] | Chr5:155344802..180693344 [GRCh37] Chr5:5q33.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:174832617-180693344)x3 | copy number gain | not provided [RCV000745336] | Chr5:174832617..180693344 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175346223-177423236)x1 | copy number loss | not provided [RCV000745338] | Chr5:175346223..177423236 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175433876-177441189)x1 | copy number loss | not provided [RCV000745339] | Chr5:175433876..177441189 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.936-210G>A | single nucleotide variant | not provided [RCV001709451] | Chr5:177514057 [GRCh38] Chr5:176941058 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1479C>T (p.Ser493=) | single nucleotide variant | DDX41-related disorder [RCV003912869]|not provided [RCV000901231]|not specified [RCV001818750] | Chr5:177512566 [GRCh38] Chr5:176939567 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.27+2_27+5dup | duplication | DDX41-related disorder [RCV003926223]|not provided [RCV000963859]|not specified [RCV001356722] | Chr5:177516913..177516914 [GRCh38] Chr5:176943914..176943915 [GRCh37] Chr5:5q35.3 |
benign |
GRCh37/hg19 5q35.2-35.3(chr5:176305543-177422876) | copy number gain | not provided [RCV000767712] | Chr5:176305543..177422876 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.597A>G (p.Lys199=) | single nucleotide variant | not provided [RCV000916174] | Chr5:177515233 [GRCh38] Chr5:176942234 [GRCh37] Chr5:5q35.3 |
likely benign |
GRCh37/hg19 5q35.3(chr5:176774402-177064884)x4 | copy number gain | not provided [RCV000848335] | Chr5:176774402..177064884 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.3(chr5:176643613-179085551)x3 | copy number gain | not provided [RCV000846590] | Chr5:176643613..179085551 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.3(chr5:176848982-180719789)x3 | copy number gain | not provided [RCV000847220] | Chr5:176848982..180719789 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.364G>T (p.Glu122Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003467511]|not provided [RCV000822333]|not specified [RCV002249532] | Chr5:177516128 [GRCh38] Chr5:176943129 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|uncertain significance |
Single allele | deletion | Marfanoid habitus and intellectual disability [RCV000851176] | Chr5:175875407..177036017 [GRCh37] Chr5:5q35.2-35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1004dup (p.Asp336fs) | duplication | not provided [RCV001008395] | Chr5:177513778..177513779 [GRCh38] Chr5:176940779..176940780 [GRCh37] Chr5:5q35.3 |
pathogenic |
GRCh37/hg19 5q35.3(chr5:176732536-177260046)x1 | copy number loss | not provided [RCV000845642] | Chr5:176732536..177260046 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:175570677-177439550)x3 | copy number gain | not provided [RCV000846148] | Chr5:175570677..177439550 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.811C>T (p.Arg271Trp) | single nucleotide variant | not provided [RCV003318299] | Chr5:177514825 [GRCh38] Chr5:176941826 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.764G>A (p.Arg255His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572889]|not provided [RCV003233208] | Chr5:177514950 [GRCh38] Chr5:176941951 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.946_947del (p.Met316fs) | deletion | DDX41-related disorder [RCV004752016]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224812]|not provided [RCV001565772] | Chr5:177513836..177513837 [GRCh38] Chr5:176940837..176940838 [GRCh37] Chr5:5q35.3 |
pathogenic |
NC_000005.9:g.(?_176289625)_(177151363_?)del | deletion | Sotos syndrome [RCV003232856]|not provided [RCV003113198] | Chr5:176289625..177151363 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic|no classifications from unflagged records |
NM_016222.4(DDX41):c.935+320C>T | single nucleotide variant | not provided [RCV001677367] | Chr5:177514381 [GRCh38] Chr5:176941382 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.27+16G>C | single nucleotide variant | not provided [RCV001687151] | Chr5:177516903 [GRCh38] Chr5:176943904 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.936-70G>A | single nucleotide variant | not provided [RCV001562494] | Chr5:177513917 [GRCh38] Chr5:176940918 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.799-36G>A | single nucleotide variant | not provided [RCV001570977] | Chr5:177514873 [GRCh38] Chr5:176941874 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.935+181G>A | single nucleotide variant | not provided [RCV001571004] | Chr5:177514520 [GRCh38] Chr5:176941521 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.572-130CT[8] | microsatellite | not provided [RCV001684154] | Chr5:177515371..177515372 [GRCh38] Chr5:176942372..176942373 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1400-42G>A | single nucleotide variant | not provided [RCV001715450] | Chr5:177512687 [GRCh38] Chr5:176939688 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1550-24G>C | single nucleotide variant | not provided [RCV001732371] | Chr5:177512417 [GRCh38] Chr5:176939418 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1621+36T>G | single nucleotide variant | not provided [RCV001545899] | Chr5:177512286 [GRCh38] Chr5:176939287 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.937G>A (p.Gly313Ser) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572888]|not provided [RCV003231772] | Chr5:177513846 [GRCh38] Chr5:176940847 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.*3C>T | single nucleotide variant | DDX41-related disorder [RCV003931186]|not provided [RCV001559753]|not specified [RCV001821887] | Chr5:177511788 [GRCh38] Chr5:176938789 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
GRCh37/hg19 5q35.3(chr5:176718361-176957659)x3 | copy number gain | not provided [RCV002472682] | Chr5:176718361..176957659 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.1-35.3(chr5:170805664-180719789)x3 | copy number gain | 5q35 microduplication syndrome [RCV001263227] | Chr5:170805664..180719789 [GRCh37] Chr5:5q35.1-35.3 |
pathogenic |
NM_016222.4(DDX41):c.935+275T>C | single nucleotide variant | not provided [RCV001620150] | Chr5:177514426 [GRCh38] Chr5:176941427 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1200C>T (p.Arg400=) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001803385]|not provided [RCV001688139] | Chr5:177513383 [GRCh38] Chr5:176940384 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.465G>A (p.Met155Ile) | single nucleotide variant | DDX41-related disorder [RCV004752033]|DDX41-related hematologic malignancy predisposition syndrome [RCV002477874]|not provided [RCV001658800]|not specified [RCV001821945] | Chr5:177515791 [GRCh38] Chr5:176942792 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.6G>T (p.Glu2Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001682625]|not provided [RCV002254968]|not specified [RCV001821952] | Chr5:177516940 [GRCh38] Chr5:176943941 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.572-42del | deletion | not provided [RCV001587125] | Chr5:177515300 [GRCh38] Chr5:176942301 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1399+46T>C | single nucleotide variant | not provided [RCV001710575] | Chr5:177512734 [GRCh38] Chr5:176939735 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1141A>T (p.Lys381Ter) | single nucleotide variant | DDX41-related disorder [RCV003394152]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224813]|not provided [RCV001583239] | Chr5:177513442 [GRCh38] Chr5:176940443 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.653G>A (p.Gly218Asp) | single nucleotide variant | DDX41-related disorder [RCV003956282]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224814]|not provided [RCV001589919]|not specified [RCV001821922] | Chr5:177515061 [GRCh38] Chr5:176942062 [GRCh37] Chr5:5q35.3 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.*97C>T | single nucleotide variant | not provided [RCV001572123] | Chr5:177511694 [GRCh38] Chr5:176938695 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.155dup (p.Arg53fs) | duplication | Myelodysplasia [RCV001256167]|not provided [RCV003222279] | Chr5:177516430..177516431 [GRCh38] Chr5:176943431..176943432 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1586_1587del (p.Thr529fs) | microsatellite | Acute myeloid leukemia [RCV001256170]|DDX41-related disorder [RCV003393927]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224810]|not provided [RCV002462887] | Chr5:177512356..177512357 [GRCh38] Chr5:176939357..176939358 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.370C>T (p.Arg124Ter) | single nucleotide variant | Myelodysplasia [RCV001256172] | Chr5:177516122 [GRCh38] Chr5:176943123 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.142C>T (p.Gln48Ter) | single nucleotide variant | Acute myeloid leukemia [RCV001256176]|DDX41-related hematologic malignancy predisposition syndrome [RCV004570648]|not provided [RCV001819963] | Chr5:177516444 [GRCh38] Chr5:176943445 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175346695-177469711)x1 | copy number loss | Sotos syndrome [RCV003232270] | Chr5:175346695..177469711 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.1668G>T (p.Lys556Asn) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001255164]|not provided [RCV002570584] | Chr5:177512160 [GRCh38] Chr5:176939161 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:175570677-177114151)x3 | copy number gain | not provided [RCV001258712] | Chr5:175570677..177114151 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.1436G>A (p.Arg479Gln) | single nucleotide variant | Bone marrow hypocellularity [RCV001256175]|DDX41-related disorder [RCV003416132]|DDX41-related hematologic malignancy predisposition syndrome [RCV003469486]|not provided [RCV001751523] | Chr5:177512609 [GRCh38] Chr5:176939610 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.517G>A (p.Gly173Arg) | single nucleotide variant | Bone marrow hypocellularity [RCV001256173]|DDX41-related hematologic malignancy predisposition syndrome [RCV001760302]|not provided [RCV002222688] | Chr5:177515739 [GRCh38] Chr5:176942740 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic|uncertain significance|not provided |
GRCh37/hg19 5q35.2-35.3(chr5:175394616-177436413)x3 | copy number gain | not provided [RCV001258713] | Chr5:175394616..177436413 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.719delinsCG (p.Ile240fs) | indel | Acute myeloid leukemia [RCV001256168] | Chr5:177514995 [GRCh38] Chr5:176941996 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.253G>T (p.Val85Phe) | single nucleotide variant | Aplastic anemia [RCV001256174] | Chr5:177516333 [GRCh38] Chr5:176943334 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1732+46A>G | single nucleotide variant | not provided [RCV001643295] | Chr5:177512050 [GRCh38] Chr5:176939051 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.882C>T (p.Cys294=) | single nucleotide variant | not provided [RCV001664973] | Chr5:177514754 [GRCh38] Chr5:176941755 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.1098+2T>G | single nucleotide variant | not provided [RCV001376969] | Chr5:177513683 [GRCh38] Chr5:176940684 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.916C>T (p.Gln306Ter) | single nucleotide variant | not provided [RCV001391006] | Chr5:177514720 [GRCh38] Chr5:176941721 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.305_306del (p.Lys102fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV002504637]|not provided [RCV001380955] | Chr5:177516186..177516187 [GRCh38] Chr5:176943187..176943188 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.1354C>T (p.Leu452=) | single nucleotide variant | DDX41-related disorder [RCV003908888]|not provided [RCV001536201]|not specified [RCV001821857] | Chr5:177512825 [GRCh38] Chr5:176939826 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.1230+80G>A | single nucleotide variant | not provided [RCV001689489] | Chr5:177513273 [GRCh38] Chr5:176940274 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1622-20C>G | single nucleotide variant | not provided [RCV001652120] | Chr5:177512226 [GRCh38] Chr5:176939227 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.936-23C>G | single nucleotide variant | not provided [RCV001685287] | Chr5:177513870 [GRCh38] Chr5:176940871 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.138+53G>A | single nucleotide variant | not provided [RCV001674974] | Chr5:177516672 [GRCh38] Chr5:176943673 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1334_1336del (p.Val445del) | deletion | not provided [RCV001755107] | Chr5:177512843..177512845 [GRCh38] Chr5:176939844..176939846 [GRCh37] Chr5:5q35.3 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:176497464-177776599)x3 | copy number gain | not provided [RCV001832980] | Chr5:176497464..177776599 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.62_63del (p.Ser21fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV001761404] | Chr5:177516800..177516801 [GRCh38] Chr5:176943801..176943802 [GRCh37] Chr5:5q35.3 |
pathogenic|not provided |
NM_016222.4(DDX41):c.32C>T (p.Ala11Val) | single nucleotide variant | not provided [RCV003126989] | Chr5:177516831 [GRCh38] Chr5:176943832 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.19G>T (p.Glu7Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001761403] | Chr5:177516927 [GRCh38] Chr5:176943928 [GRCh37] Chr5:5q35.3 |
pathogenic|not provided |
NM_016222.4(DDX41):c.776A>G (p.Tyr259Cys) | single nucleotide variant | DDX41-related disorder [RCV003394244]|DDX41-related hematologic malignancy predisposition syndrome [RCV001761406] | Chr5:177514938 [GRCh38] Chr5:176941939 [GRCh37] Chr5:5q35.3 |
pathogenic|uncertain significance|not provided |
GRCh37/hg19 5q32-35.3(chr5:149010383-180719789) | copy number gain | Hunter-McAlpine craniosynostosis [RCV002280612] | Chr5:149010383..180719789 [GRCh37] Chr5:5q32-35.3 |
pathogenic |
NM_016222.4(DDX41):c.38C>T (p.Thr13Ile) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003470888]|not provided [RCV001769396]|not specified [RCV001821994] | Chr5:177516825 [GRCh38] Chr5:176943826 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1496dup (p.Ala500fs) | duplication | DDX41-related hematologic malignancy predisposition syndrome [RCV001761407]|not provided [RCV001821989] | Chr5:177512548..177512549 [GRCh38] Chr5:176939549..176939550 [GRCh37] Chr5:5q35.3 |
pathogenic|not provided |
NM_016222.4(DDX41):c.7G>A (p.Glu3Lys) | single nucleotide variant | not provided [RCV001752299] | Chr5:177516939 [GRCh38] Chr5:176943940 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.449G>A (p.Arg150His) | single nucleotide variant | not provided [RCV001764043] | Chr5:177515807 [GRCh38] Chr5:176942808 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.475C>T (p.Arg159Ter) | single nucleotide variant | DDX41-related disorder [RCV004752052]|DDX41-related hematologic malignancy predisposition syndrome [RCV003464144]|not provided [RCV001794717] | Chr5:177515781 [GRCh38] Chr5:176942782 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.931C>T (p.Arg311Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003470918]|Inherited acute myeloid leukemia [RCV003313232]|not provided [RCV001794600] | Chr5:177514705 [GRCh38] Chr5:176941706 [GRCh37] Chr5:5q35.3 |
pathogenic|uncertain significance |
NM_016222.4(DDX41):c.491G>A (p.Arg164Gln) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571078]|not provided [RCV001769158] | Chr5:177515765 [GRCh38] Chr5:176942766 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.103C>G (p.Pro35Ala) | single nucleotide variant | not provided [RCV001769164] | Chr5:177516760 [GRCh38] Chr5:176943761 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1301C>T (p.Pro434Leu) | single nucleotide variant | not provided [RCV001769361] | Chr5:177513012 [GRCh38] Chr5:176940013 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.455T>G (p.Val152Gly) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001761405] | Chr5:177515801 [GRCh38] Chr5:176942802 [GRCh37] Chr5:5q35.3 |
pathogenic|not provided |
NM_016222.4(DDX41):c.1075C>T (p.Arg359Cys) | single nucleotide variant | not provided [RCV001760714] | Chr5:177513708 [GRCh38] Chr5:176940709 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1471G>A (p.Val491Ile) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571077]|not provided [RCV001769135] | Chr5:177512574 [GRCh38] Chr5:176939575 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.617C>T (p.Pro206Leu) | single nucleotide variant | not provided [RCV001774581] | Chr5:177515213 [GRCh38] Chr5:176942214 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.560A>G (p.Lys187Arg) | single nucleotide variant | not provided [RCV001763661]|not specified [RCV001821991] | Chr5:177515696 [GRCh38] Chr5:176942697 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1283T>C (p.Leu428Pro) | single nucleotide variant | not provided [RCV002542539]|not specified [RCV001817527] | Chr5:177513030 [GRCh38] Chr5:176940031 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.198C>A (p.Ser66Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003464150]|not specified [RCV001817570] | Chr5:177516388 [GRCh38] Chr5:176943389 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.643A>C (p.Ile215Leu) | single nucleotide variant | DDX41-related disorder [RCV003892180]|DDX41-related hematologic malignancy predisposition syndrome [RCV003470919]|not provided [RCV001794706] | Chr5:177515187 [GRCh38] Chr5:176942188 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.566C>T (p.Pro189Leu) | single nucleotide variant | not provided [RCV003772284]|not specified [RCV001817250] | Chr5:177515690 [GRCh38] Chr5:176942691 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1299G>A (p.Pro433=) | single nucleotide variant | DDX41-related disorder [RCV003956393]|not provided [RCV002541982]|not specified [RCV001817261] | Chr5:177513014 [GRCh38] Chr5:176940015 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.511G>C (p.Val171Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003464149]|not provided [RCV002463042]|not specified [RCV001817302] | Chr5:177515745 [GRCh38] Chr5:176942746 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.644T>C (p.Ile215Thr) | single nucleotide variant | not provided [RCV001779711] | Chr5:177515186 [GRCh38] Chr5:176942187 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.571G>A (p.Ala191Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV001802385]|not provided [RCV002222729] | Chr5:177515685 [GRCh38] Chr5:176942686 [GRCh37] Chr5:5q35.3 |
likely pathogenic|uncertain significance |
NM_016222.4(DDX41):c.773C>T (p.Pro258Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003464151]|not provided [RCV001817854] | Chr5:177514941 [GRCh38] Chr5:176941942 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.986del (p.Gln329fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV003224818]|not provided [RCV001817876] | Chr5:177513797 [GRCh38] Chr5:176940798 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1108C>T (p.Gln370Ter) | single nucleotide variant | not provided [RCV001817919] | Chr5:177513475 [GRCh38] Chr5:176940476 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.959C>T (p.Thr320Ile) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224819]|not specified [RCV001817963] | Chr5:177513824 [GRCh38] Chr5:176940825 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1650G>A (p.Ala550=) | single nucleotide variant | not provided [RCV003728024]|not specified [RCV001819526] | Chr5:177512178 [GRCh38] Chr5:176939179 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.690C>G (p.Gly230=) | single nucleotide variant | DDX41-related disorder [RCV003913404]|not provided [RCV003772303]|not specified [RCV001819568] | Chr5:177515024 [GRCh38] Chr5:176942025 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.88G>T (p.Asp30Tyr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571114]|not provided [RCV002463044]|not specified [RCV001819622] | Chr5:177516775 [GRCh38] Chr5:176943776 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.877C>T (p.Arg293Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003470928]|not provided [RCV002542042]|not specified [RCV001820325] | Chr5:177514759 [GRCh38] Chr5:176941760 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1332C>T (p.Asp444=) | single nucleotide variant | not provided [RCV003772316]|not specified [RCV001820438] | Chr5:177512847 [GRCh38] Chr5:176939848 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.1033G>A (p.Glu345Lys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224815]|not specified [RCV001820469] | Chr5:177513750 [GRCh38] Chr5:176940751 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.157C>G (p.Arg53Gly) | single nucleotide variant | not specified [RCV001820524] | Chr5:177516429 [GRCh38] Chr5:176943430 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1827C>T (p.Ile609=) | single nucleotide variant | not provided [RCV003546724]|not specified [RCV001820700] | Chr5:177511833 [GRCh38] Chr5:176938834 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1079C>T (p.Thr360Ile) | single nucleotide variant | not specified [RCV001820738] | Chr5:177513704 [GRCh38] Chr5:176940705 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1622-5C>G | single nucleotide variant | not provided [RCV002541955]|not specified [RCV001822201] | Chr5:177512211 [GRCh38] Chr5:176939212 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.138+5G>A | single nucleotide variant | DDX41-related disorder [RCV003968573]|DDX41-related hematologic malignancy predisposition syndrome [RCV002291769]|Inborn genetic diseases [RCV004611882]|not provided [RCV002509703]|not specified [RCV001817337] | Chr5:177516720 [GRCh38] Chr5:176943721 [GRCh37] Chr5:5q35.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1622-3C>T | single nucleotide variant | DDX41-related disorder [RCV003948751]|not provided [RCV002542650]|not specified [RCV001822414] | Chr5:177512209 [GRCh38] Chr5:176939210 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.5A>C (p.Glu2Ala) | single nucleotide variant | not specified [RCV001822419] | Chr5:177516941 [GRCh38] Chr5:176943942 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.*181C>G | single nucleotide variant | not specified [RCV001817569] | Chr5:177511610 [GRCh38] Chr5:176938611 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.51T>G (p.Pro17=) | single nucleotide variant | not provided [RCV002542657]|not specified [RCV001822513] | Chr5:177516812 [GRCh38] Chr5:176943813 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.434+1G>C | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224817]|not provided [RCV001817863] | Chr5:177515928 [GRCh38] Chr5:176942929 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.1474dup (p.Ala492fs) | duplication | not provided [RCV001817864] | Chr5:177512570..177512571 [GRCh38] Chr5:176939571..176939572 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1394del (p.Gly465fs) | deletion | not provided [RCV001817880] | Chr5:177512785 [GRCh38] Chr5:176939786 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1721del (p.Leu574fs) | deletion | not provided [RCV001817943] | Chr5:177512107 [GRCh38] Chr5:176939108 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.*194A>G | single nucleotide variant | not specified [RCV001819409] | Chr5:177511597 [GRCh38] Chr5:176938598 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.926C>T (p.Thr309Ile) | single nucleotide variant | not specified [RCV001819456] | Chr5:177514710 [GRCh38] Chr5:176941711 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1013G>A (p.Cys338Tyr) | single nucleotide variant | DDX41-related disorder [RCV003401736]|not specified [RCV001819524] | Chr5:177513770 [GRCh38] Chr5:176940771 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1458A>G (p.Leu486=) | single nucleotide variant | not specified [RCV001819613] | Chr5:177512587 [GRCh38] Chr5:176939588 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1470C>T (p.Asp490=) | single nucleotide variant | DDX41-related disorder [RCV003941158]|not provided [RCV002542596]|not specified [RCV001820243] | Chr5:177512575 [GRCh38] Chr5:176939576 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.741G>A (p.Glu247=) | single nucleotide variant | DDX41-related disorder [RCV003911034]|not provided [RCV002542620]|not specified [RCV001820404] | Chr5:177514973 [GRCh38] Chr5:176941974 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.*63T>C | single nucleotide variant | not specified [RCV001820443] | Chr5:177511728 [GRCh38] Chr5:176938729 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.936-7T>G | single nucleotide variant | not specified [RCV001822368] | Chr5:177513854 [GRCh38] Chr5:176940855 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.645-10C>T | single nucleotide variant | DDX41-related disorder [RCV003948750]|not specified [RCV001822411] | Chr5:177515079 [GRCh38] Chr5:176942080 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.301C>T (p.Arg101Cys) | single nucleotide variant | not specified [RCV001822428] | Chr5:177516191 [GRCh38] Chr5:176943192 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1547A>G (p.Tyr516Cys) | single nucleotide variant | DDX41-related disorder [RCV003401737]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224816]|not provided [RCV003728032]|not specified [RCV001822438] | Chr5:177512498 [GRCh38] Chr5:176939499 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1399+10G>A | single nucleotide variant | not provided [RCV002545171]|not specified [RCV001822471] | Chr5:177512770 [GRCh38] Chr5:176939771 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.681G>C (p.Thr227=) | single nucleotide variant | not specified [RCV001822616] | Chr5:177515033 [GRCh38] Chr5:176942034 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.97T>C (p.Tyr33His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003325235]|not provided [RCV002542667]|not specified [RCV001822617] | Chr5:177516766 [GRCh38] Chr5:176943767 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.766G>A (p.Glu256Lys) | single nucleotide variant | DDX41-related disorder [RCV004731184]|not provided [RCV004591586]|not specified [RCV001822651] | Chr5:177514948 [GRCh38] Chr5:176941949 [GRCh37] Chr5:5q35.3 |
likely pathogenic|uncertain significance |
NM_016222.4(DDX41):c.291G>A (p.Lys97=) | single nucleotide variant | DDX41-related disorder [RCV003948754]|not provided [RCV002542690]|not specified [RCV001822788] | Chr5:177516295 [GRCh38] Chr5:176943296 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.299-3C>T | single nucleotide variant | not provided [RCV002542695]|not specified [RCV001822807] | Chr5:177516196 [GRCh38] Chr5:176943197 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1285C>T (p.Gln429Ter) | single nucleotide variant | not provided [RCV001822830] | Chr5:177513028 [GRCh38] Chr5:176940029 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.740A>G (p.Glu247Gly) | single nucleotide variant | not provided [RCV001810386] | Chr5:177514974 [GRCh38] Chr5:176941975 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.268C>T (p.Gln90Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003471290]|Inborn genetic diseases [RCV002551236]|not provided [RCV002052330] | Chr5:177516318 [GRCh38] Chr5:176943319 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NC_000005.9:g.(?_176047812)_(177422934_?)del | deletion | Ehlers-Danlos syndrome progeroid type [RCV001931790] | Chr5:176047812..177422934 [GRCh37] Chr5:5q35.2-35.3 |
uncertain significance |
NC_000005.9:g.(?_176047812)_(177422934_?)dup | duplication | Ehlers-Danlos syndrome progeroid type [RCV001883344]|not provided [RCV001879660] | Chr5:176047812..177422934 [GRCh37] Chr5:5q35.2-35.3 |
uncertain significance |
NC_000005.9:g.(?_175158654)_(179263593_?)dup | duplication | Ehlers-Danlos syndrome, dermatosparaxis type [RCV003116717]|Sotos syndrome [RCV003232857]|not provided [RCV003154288] | Chr5:175158654..179263593 [GRCh37] Chr5:5q35.2-35.3 |
uncertain significance|no classifications from unflagged records |
NC_000005.9:g.(?_176618865)_(177036696_?)dup | duplication | Sotos syndrome [RCV003232859] | Chr5:176618865..177036696 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.572-3T>C | single nucleotide variant | not provided [RCV003121073] | Chr5:177515261 [GRCh38] Chr5:176942262 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NC_000005.9:g.(?_176935330)_(176942071_?)del | deletion | not provided [RCV003119723] | Chr5:176935330..176942071 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.43G>A (p.Glu15Lys) | single nucleotide variant | not provided [RCV003327758] | Chr5:177516820 [GRCh38] Chr5:176943821 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.673G>A (p.Ala225Thr) | single nucleotide variant | Inborn genetic diseases [RCV003242715] | Chr5:177515041 [GRCh38] Chr5:176942042 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1354del (p.Leu452fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV004572860]|not provided [RCV003151500] | Chr5:177512825 [GRCh38] Chr5:176939826 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1739G>A (p.Arg580His) | single nucleotide variant | not provided [RCV003149185] | Chr5:177511921 [GRCh38] Chr5:176938922 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1621+5G>T | single nucleotide variant | Myelodysplastic syndrome [RCV002272707] | Chr5:177512317 [GRCh38] Chr5:176939318 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1828G>A (p.Gly610Ser) | single nucleotide variant | not provided [RCV003156577] | Chr5:177511832 [GRCh38] Chr5:176938833 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1105C>T (p.Arg369Ter) | single nucleotide variant | not provided [RCV002260867] | Chr5:177513478 [GRCh38] Chr5:176940479 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.1308C>T (p.Leu436=) | single nucleotide variant | DDX41-related disorder [RCV004750719]|not provided [RCV002269750] | Chr5:177512871 [GRCh38] Chr5:176939872 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 5q35.1-35.3(chr5:170350336-180719789)x3 | copy number gain | See cases [RCV002292398] | Chr5:170350336..180719789 [GRCh37] Chr5:5q35.1-35.3 |
pathogenic |
NM_016222.4(DDX41):c.920T>C (p.Met307Thr) | single nucleotide variant | not provided [RCV003778904]|not specified [RCV003151502] | Chr5:177514716 [GRCh38] Chr5:176941717 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:176516440-177773252)x3 | copy number gain | not provided [RCV002474595] | Chr5:176516440..177773252 [GRCh37] Chr5:5q35.2-35.3 |
likely pathogenic |
GRCh37/hg19 5q35.3(chr5:176616151-177107778)x3 | copy number gain | not provided [RCV002472763] | Chr5:176616151..177107778 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:176547912-177126647)x3 | copy number gain | not provided [RCV002472528] | Chr5:176547912..177126647 [GRCh37] Chr5:5q35.2-35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1302+6_1302+40del | deletion | not provided [RCV003156491] | Chr5:177512971..177513005 [GRCh38] Chr5:176939972..176940006 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.107A>G (p.Tyr36Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571171]|not provided [RCV002467271] | Chr5:177516756 [GRCh38] Chr5:176943757 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.616C>G (p.Pro206Ala) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572861]|not provided [RCV003443177]|not specified [RCV003151501] | Chr5:177515214 [GRCh38] Chr5:176942215 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.199G>T (p.Gly67Cys) | single nucleotide variant | not provided [RCV002298086] | Chr5:177516387 [GRCh38] Chr5:176943388 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1231-5G>A | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572227]|not provided [RCV002306325] | Chr5:177513087 [GRCh38] Chr5:176940088 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.19G>A (p.Glu7Lys) | single nucleotide variant | not provided [RCV002298057] | Chr5:177516927 [GRCh38] Chr5:176943928 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1789A>G (p.Lys597Glu) | single nucleotide variant | not provided [RCV002298023] | Chr5:177511871 [GRCh38] Chr5:176938872 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1549+9C>G | single nucleotide variant | not provided [RCV002730250] | Chr5:177512487 [GRCh38] Chr5:176939488 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.984G>A (p.Leu328=) | single nucleotide variant | not provided [RCV002750782] | Chr5:177513799 [GRCh38] Chr5:176940800 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.907G>A (p.Val303Met) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003464563]|not provided [RCV002461646] | Chr5:177514729 [GRCh38] Chr5:176941730 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1733-3C>T | single nucleotide variant | not provided [RCV002756396] | Chr5:177511930 [GRCh38] Chr5:176938931 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1377C>T (p.Ala459=) | single nucleotide variant | not provided [RCV002613657] | Chr5:177512802 [GRCh38] Chr5:176939803 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.94G>A (p.Asp32Asn) | single nucleotide variant | not provided [RCV002616016] | Chr5:177516769 [GRCh38] Chr5:176943770 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.298+20C>T | single nucleotide variant | not provided [RCV002971866] | Chr5:177516268 [GRCh38] Chr5:176943269 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1230+15C>T | single nucleotide variant | not provided [RCV002863420] | Chr5:177513338 [GRCh38] Chr5:176940339 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+5C>T | single nucleotide variant | not provided [RCV002995962] | Chr5:177513680 [GRCh38] Chr5:176940681 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.65G>A (p.Arg22His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465887]|not provided [RCV002994735] | Chr5:177516798 [GRCh38] Chr5:176943799 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.113C>G (p.Pro38Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572481]|not provided [RCV002971253] | Chr5:177516750 [GRCh38] Chr5:176943751 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1018T>A (p.Tyr340Asn) | single nucleotide variant | not provided [RCV002686237] | Chr5:177513765 [GRCh38] Chr5:176940766 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1621+18G>A | single nucleotide variant | not provided [RCV003014299] | Chr5:177512304 [GRCh38] Chr5:176939305 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.751C>T (p.Pro251Ser) | single nucleotide variant | Inborn genetic diseases [RCV002687166]|not provided [RCV003232844] | Chr5:177514963 [GRCh38] Chr5:176941964 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.565C>T (p.Pro189Ser) | single nucleotide variant | not provided [RCV002614365] | Chr5:177515691 [GRCh38] Chr5:176942692 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.199G>C (p.Gly67Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572822]|Inborn genetic diseases [RCV002883039]|not provided [RCV003443153] | Chr5:177516387 [GRCh38] Chr5:176943388 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1704C>T (p.Cys568=) | single nucleotide variant | not provided [RCV002690104] | Chr5:177512124 [GRCh38] Chr5:176939125 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.219T>G (p.Asp73Glu) | single nucleotide variant | Inborn genetic diseases [RCV002818721] | Chr5:177516367 [GRCh38] Chr5:176943368 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.847del (p.Leu283fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV003224822]|not provided [RCV002461846] | Chr5:177514789 [GRCh38] Chr5:176941790 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.655C>T (p.Arg219Cys) | single nucleotide variant | Inborn genetic diseases [RCV002662804]|not provided [RCV002662803] | Chr5:177515059 [GRCh38] Chr5:176942060 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.459G>C (p.Leu153=) | single nucleotide variant | not provided [RCV003002838] | Chr5:177515797 [GRCh38] Chr5:176942798 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1693G>T (p.Val565Leu) | single nucleotide variant | not provided [RCV002825616] | Chr5:177512135 [GRCh38] Chr5:176939136 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.935+12C>T | single nucleotide variant | not provided [RCV002734986] | Chr5:177514689 [GRCh38] Chr5:176941690 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1302+8C>T | single nucleotide variant | not provided [RCV002619115] | Chr5:177513003 [GRCh38] Chr5:176940004 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.374-14G>A | single nucleotide variant | not provided [RCV002781358] | Chr5:177516003 [GRCh38] Chr5:176943004 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1192G>C (p.Val398Leu) | single nucleotide variant | Inborn genetic diseases [RCV002822997] | Chr5:177513391 [GRCh38] Chr5:176940392 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.384A>G (p.Ser128=) | single nucleotide variant | not provided [RCV003054262] | Chr5:177515979 [GRCh38] Chr5:176942980 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.935+11G>A | single nucleotide variant | not provided [RCV002795632] | Chr5:177514690 [GRCh38] Chr5:176941691 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.814C>T (p.Gln272Ter) | single nucleotide variant | not provided [RCV003037519] | Chr5:177514822 [GRCh38] Chr5:176941823 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1046T>A (p.Met349Lys) | single nucleotide variant | not provided [RCV003037027] | Chr5:177513737 [GRCh38] Chr5:176940738 [GRCh37] Chr5:5q35.3 |
likely pathogenic|conflicting interpretations of pathogenicity |
NM_016222.4(DDX41):c.1755C>T (p.Cys585=) | single nucleotide variant | not provided [RCV002620004] | Chr5:177511905 [GRCh38] Chr5:176938906 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.59G>A (p.Gly20Glu) | single nucleotide variant | not provided [RCV002999046] | Chr5:177516804 [GRCh38] Chr5:176943805 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.434+14G>C | single nucleotide variant | not provided [RCV002590712] | Chr5:177515915 [GRCh38] Chr5:176942916 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.538A>G (p.Ile180Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003325244]|Inborn genetic diseases [RCV003080932]|not provided [RCV003080933] | Chr5:177515718 [GRCh38] Chr5:176942719 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.718A>G (p.Ile240Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465781]|not provided [RCV002571632] | Chr5:177514996 [GRCh38] Chr5:176941997 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1411C>T (p.Arg471Trp) | single nucleotide variant | not provided [RCV002975737] | Chr5:177512634 [GRCh38] Chr5:176939635 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1098+11C>T | single nucleotide variant | not provided [RCV002590859] | Chr5:177513674 [GRCh38] Chr5:176940675 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.49C>T (p.Pro17Ser) | single nucleotide variant | not provided [RCV002695440] | Chr5:177516814 [GRCh38] Chr5:176943815 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1684G>A (p.Val562Met) | single nucleotide variant | not provided [RCV002785586] | Chr5:177512144 [GRCh38] Chr5:176939145 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.113C>T (p.Pro38Leu) | single nucleotide variant | not provided [RCV002636593] | Chr5:177516750 [GRCh38] Chr5:176943751 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.139-17C>T | single nucleotide variant | not provided [RCV002569484] | Chr5:177516464 [GRCh38] Chr5:176943465 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1532A>G (p.Glu511Gly) | single nucleotide variant | not provided [RCV002592945] | Chr5:177512513 [GRCh38] Chr5:176939514 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.82G>A (p.Glu28Lys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571822]|not provided [RCV002926659] | Chr5:177516781 [GRCh38] Chr5:176943782 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1602C>T (p.Thr534=) | single nucleotide variant | not provided [RCV002622068] | Chr5:177512341 [GRCh38] Chr5:176939342 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.434+12C>T | single nucleotide variant | not provided [RCV002824589] | Chr5:177515917 [GRCh38] Chr5:176942918 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.299-16C>T | single nucleotide variant | not provided [RCV003038799] | Chr5:177516209 [GRCh38] Chr5:176943210 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.373+18A>C | single nucleotide variant | not provided [RCV002790285] | Chr5:177516101 [GRCh38] Chr5:176943102 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1733-18_1733-17del | deletion | not provided [RCV002596679] | Chr5:177511944..177511945 [GRCh38] Chr5:176938945..176938946 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+12G>A | single nucleotide variant | not provided [RCV002573698] | Chr5:177513673 [GRCh38] Chr5:176940674 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1099-20G>A | single nucleotide variant | not provided [RCV002790894] | Chr5:177513504 [GRCh38] Chr5:176940505 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.577C>G (p.Leu193Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465885]|not provided [RCV003007258] | Chr5:177515253 [GRCh38] Chr5:176942254 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1549+15C>T | single nucleotide variant | not provided [RCV002596821] | Chr5:177512481 [GRCh38] Chr5:176939482 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1015C>T (p.Arg339Cys) | single nucleotide variant | not provided [RCV003059929] | Chr5:177513768 [GRCh38] Chr5:176940769 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1234G>A (p.Val412Ile) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465789]|not provided [RCV002594360] | Chr5:177513079 [GRCh38] Chr5:176940080 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1732+19C>A | single nucleotide variant | not provided [RCV002576044] | Chr5:177512077 [GRCh38] Chr5:176939078 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.449G>T (p.Arg150Leu) | single nucleotide variant | not provided [RCV002627354] | Chr5:177515807 [GRCh38] Chr5:176942808 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.345G>A (p.Lys115=) | single nucleotide variant | not provided [RCV002642806] | Chr5:177516147 [GRCh38] Chr5:176943148 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.571+13T>G | single nucleotide variant | not provided [RCV002790210] | Chr5:177515672 [GRCh38] Chr5:176942673 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.522C>T (p.Asp174=) | single nucleotide variant | not provided [RCV002667370] | Chr5:177515734 [GRCh38] Chr5:176942735 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.591G>A (p.Lys197=) | single nucleotide variant | DDX41-related disorder [RCV003961174]|not provided [RCV002917777] | Chr5:177515239 [GRCh38] Chr5:176942240 [GRCh37] Chr5:5q35.3 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_016222.4(DDX41):c.1549+8C>T | single nucleotide variant | not provided [RCV002917805] | Chr5:177512488 [GRCh38] Chr5:176939489 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.551A>G (p.Lys184Arg) | single nucleotide variant | not provided [RCV002623773] | Chr5:177515705 [GRCh38] Chr5:176942706 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1275C>T (p.Leu425=) | single nucleotide variant | DDX41-related disorder [RCV003896238]|not provided [RCV002574363] | Chr5:177513038 [GRCh38] Chr5:176940039 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.518G>A (p.Gly173Glu) | single nucleotide variant | not provided [RCV002851507] | Chr5:177515738 [GRCh38] Chr5:176942739 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.420C>G (p.Asp140Glu) | single nucleotide variant | not provided [RCV003041783] | Chr5:177515943 [GRCh38] Chr5:176942944 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.765C>T (p.Arg255=) | single nucleotide variant | not provided [RCV002595060] | Chr5:177514949 [GRCh38] Chr5:176941950 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.484C>T (p.Arg162Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465822]|not provided [RCV002711775] | Chr5:177515772 [GRCh38] Chr5:176942773 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.799-9dup | duplication | not provided [RCV002667143] | Chr5:177514845..177514846 [GRCh38] Chr5:176941846..176941847 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.572-14G>A | single nucleotide variant | not provided [RCV002871608] | Chr5:177515272 [GRCh38] Chr5:176942273 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.472G>A (p.Glu158Lys) | single nucleotide variant | Inborn genetic diseases [RCV002743277] | Chr5:177515784 [GRCh38] Chr5:176942785 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1528C>T (p.Pro510Ser) | single nucleotide variant | DDX41-related disorder [RCV004750770]|not provided [RCV002766518] | Chr5:177512517 [GRCh38] Chr5:176939518 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.434+1G>A | single nucleotide variant | not provided [RCV002626364] | Chr5:177515928 [GRCh38] Chr5:176942929 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.1099-1G>A | single nucleotide variant | not provided [RCV002876148] | Chr5:177513485 [GRCh38] Chr5:176940486 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1399+17C>T | single nucleotide variant | not provided [RCV002828445] | Chr5:177512763 [GRCh38] Chr5:176939764 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.804G>A (p.Glu268=) | single nucleotide variant | not provided [RCV002982375] | Chr5:177514832 [GRCh38] Chr5:176941833 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1400-19_1400-16del | deletion | not provided [RCV002574261] | Chr5:177512661..177512664 [GRCh38] Chr5:176939662..176939665 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.1509C>T (p.His503=) | single nucleotide variant | DDX41-related disorder [RCV003973434]|not provided [RCV002581064] | Chr5:177512536 [GRCh38] Chr5:176939537 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+20A>G | single nucleotide variant | not provided [RCV003048443] | Chr5:177513665 [GRCh38] Chr5:176940666 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1431del (p.Phe478fs) | deletion | not provided [RCV003045867] | Chr5:177512614 [GRCh38] Chr5:176939615 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1577C>T (p.Ser526Leu) | single nucleotide variant | not provided [RCV002576966] | Chr5:177512366 [GRCh38] Chr5:176939367 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.707C>T (p.Thr236Met) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571183]|not provided [RCV002600546] | Chr5:177515007 [GRCh38] Chr5:176942008 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1569C>T (p.Thr523=) | single nucleotide variant | not provided [RCV002651238] | Chr5:177512374 [GRCh38] Chr5:176939375 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1050C>T (p.Ile350=) | single nucleotide variant | not provided [RCV002629141] | Chr5:177513733 [GRCh38] Chr5:176940734 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.139-5C>T | single nucleotide variant | DDX41-related disorder [RCV003906514]|Inborn genetic diseases [RCV004614359]|not provided [RCV002598633] | Chr5:177516452 [GRCh38] Chr5:176943453 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.1276G>A (p.Glu426Lys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571187]|not provided [RCV002630416] | Chr5:177513037 [GRCh38] Chr5:176940038 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.809C>T (p.Ala270Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004571186]|not provided [RCV002598260] | Chr5:177514827 [GRCh38] Chr5:176941828 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1347C>T (p.His449=) | single nucleotide variant | DDX41-related disorder [RCV004750820]|not provided [RCV003088731] | Chr5:177512832 [GRCh38] Chr5:176939833 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1611C>T (p.Asn537=) | single nucleotide variant | not provided [RCV002898556] | Chr5:177512332 [GRCh38] Chr5:176939333 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.986AGA[2] (p.Lys331del) | microsatellite | not provided [RCV002598701] | Chr5:177513789..177513791 [GRCh38] Chr5:176940790..176940792 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.189G>C (p.Gln63His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003465959]|Inborn genetic diseases [RCV003092780]|not provided [RCV003086706] | Chr5:177516397 [GRCh38] Chr5:176943398 [GRCh37] Chr5:5q35.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1621+3G>A | single nucleotide variant | DDX41-related disorder [RCV003943427]|not provided [RCV002576640] | Chr5:177512319 [GRCh38] Chr5:176939320 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.124C>T (p.Arg42Cys) | single nucleotide variant | not provided [RCV003030535] | Chr5:177516739 [GRCh38] Chr5:176943740 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.799-12C>T | single nucleotide variant | not provided [RCV002646067] | Chr5:177514849 [GRCh38] Chr5:176941850 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.96C>T (p.Asp32=) | single nucleotide variant | not provided [RCV002857777] | Chr5:177516767 [GRCh38] Chr5:176943768 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.572-4A>G | single nucleotide variant | not provided [RCV002715673] | Chr5:177515262 [GRCh38] Chr5:176942263 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1059C>T (p.Gly353=) | single nucleotide variant | not provided [RCV002630860] | Chr5:177513724 [GRCh38] Chr5:176940725 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.28-14G>C | single nucleotide variant | not provided [RCV002646771] | Chr5:177516849 [GRCh38] Chr5:176943850 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1296C>G (p.Pro432=) | single nucleotide variant | not provided [RCV003093121] | Chr5:177513017 [GRCh38] Chr5:176940018 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.578T>C (p.Leu193Pro) | single nucleotide variant | not provided [RCV003032107] | Chr5:177515252 [GRCh38] Chr5:176942253 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.479A>G (p.His160Arg) | single nucleotide variant | not provided [RCV002605275] | Chr5:177515777 [GRCh38] Chr5:176942778 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+7G>T | single nucleotide variant | not provided [RCV002605831] | Chr5:177516912 [GRCh38] Chr5:176943913 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.401A>G (p.Lys134Arg) | single nucleotide variant | Inborn genetic diseases [RCV003161964]|not provided [RCV002606768] | Chr5:177515962 [GRCh38] Chr5:176942963 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.633C>T (p.Gly211=) | single nucleotide variant | not provided [RCV003066758] | Chr5:177515197 [GRCh38] Chr5:176942198 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.777T>C (p.Tyr259=) | single nucleotide variant | not provided [RCV002588346] | Chr5:177514937 [GRCh38] Chr5:176941938 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1732+13C>T | single nucleotide variant | not provided [RCV002588901] | Chr5:177512083 [GRCh38] Chr5:176939084 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1621+9G>A | single nucleotide variant | not provided [RCV002612117] | Chr5:177512313 [GRCh38] Chr5:176939314 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1098+6G>A | single nucleotide variant | DDX41-related disorder [RCV003963696]|not provided [RCV002612203] | Chr5:177513679 [GRCh38] Chr5:176940680 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.1106G>A (p.Arg369Gln) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224845]|not provided [RCV004765776] | Chr5:177513477 [GRCh38] Chr5:176940478 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1589G>A (p.Gly530Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224841]|not provided [RCV003561243] | Chr5:177512354 [GRCh38] Chr5:176939355 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1238A>C (p.Glu413Ala) | single nucleotide variant | not provided [RCV003225281] | Chr5:177513075 [GRCh38] Chr5:176940076 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.164G>A (p.Arg55His) | single nucleotide variant | not provided [RCV003229183] | Chr5:177516422 [GRCh38] Chr5:176943423 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.523G>A (p.Gly175Ser) | single nucleotide variant | not provided [RCV003229248] | Chr5:177515733 [GRCh38] Chr5:176942734 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1030G>T (p.Asp344Tyr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003230304]|not provided [RCV003219022] | Chr5:177513753 [GRCh38] Chr5:176940754 [GRCh37] Chr5:5q35.3 |
likely pathogenic|conflicting interpretations of pathogenicity |
NM_016222.4(DDX41):c.1036G>C (p.Ala346Pro) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224840] | Chr5:177513747 [GRCh38] Chr5:176940748 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.962C>T (p.Pro321Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224849] | Chr5:177513821 [GRCh38] Chr5:176940822 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.715G>A (p.Val239Ile) | single nucleotide variant | Inborn genetic diseases [RCV003286750]|not provided [RCV004765788] | Chr5:177514999 [GRCh38] Chr5:176942000 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1237G>A (p.Glu413Lys) | single nucleotide variant | not provided [RCV003223889] | Chr5:177513076 [GRCh38] Chr5:176940077 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.935+4A>T | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224834]|Inborn genetic diseases [RCV004285603] | Chr5:177514697 [GRCh38] Chr5:176941698 [GRCh37] Chr5:5q35.3 |
pathogenic|uncertain significance |
NM_016222.4(DDX41):c.1035G>C (p.Glu345Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224839] | Chr5:177513748 [GRCh38] Chr5:176940749 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.423del (p.Ile142fs) | deletion | DDX41-related disorder [RCV003410309]|DDX41-related hematologic malignancy predisposition syndrome [RCV003224847] | Chr5:177515940 [GRCh38] Chr5:176942941 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.435-1G>T | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224848] | Chr5:177515822 [GRCh38] Chr5:176942823 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.421C>T (p.Pro141Ser) | single nucleotide variant | not provided [RCV003225405] | Chr5:177515942 [GRCh38] Chr5:176942943 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.191A>G (p.Gln64Arg) | single nucleotide variant | Inborn genetic diseases [RCV003205115] | Chr5:177516395 [GRCh38] Chr5:176943396 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1395C>T (p.Gly465=) | single nucleotide variant | not provided [RCV003159428] | Chr5:177512784 [GRCh38] Chr5:176939785 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1303-6G>A | single nucleotide variant | not provided [RCV003159465] | Chr5:177512882 [GRCh38] Chr5:176939883 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1126G>A (p.Ala376Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224844] | Chr5:177513457 [GRCh38] Chr5:176940458 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1709A>G (p.Asp570Gly) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224846] | Chr5:177512119 [GRCh38] Chr5:176939120 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1119C>T (p.Leu373=) | single nucleotide variant | not provided [RCV003218900] | Chr5:177513464 [GRCh38] Chr5:176940465 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.647T>C (p.Leu216Pro) | single nucleotide variant | not provided [RCV003219111] | Chr5:177515067 [GRCh38] Chr5:176942068 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1603_1605delinsA (p.Phe535fs) | indel | DDX41-related hematologic malignancy predisposition syndrome [RCV003224835] | Chr5:177512338..177512340 [GRCh38] Chr5:176939339..176939341 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1231-3C>G | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224836] | Chr5:177513085 [GRCh38] Chr5:176940086 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1088_1090del (p.Ser363del) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV003224837]|not provided [RCV003779803] | Chr5:177513693..177513695 [GRCh38] Chr5:176940694..176940696 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.638C>G (p.Pro213Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224838] | Chr5:177515192 [GRCh38] Chr5:176942193 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1204G>T (p.Gly402Trp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224842] | Chr5:177513379 [GRCh38] Chr5:176940380 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1759G>T (p.Gly587Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003224843] | Chr5:177511901 [GRCh38] Chr5:176938902 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.878G>A (p.Arg293His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003325297]|not provided [RCV003777362] | Chr5:177514758 [GRCh38] Chr5:176941759 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.656G>A (p.Arg219His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003459836]|not provided [RCV003319640] | Chr5:177515058 [GRCh38] Chr5:176942059 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.799C>T (p.Arg267Trp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466057]|not provided [RCV003321376] | Chr5:177514837 [GRCh38] Chr5:176941838 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1563C>T (p.Gly521=) | single nucleotide variant | not provided [RCV003330032] | Chr5:177512380 [GRCh38] Chr5:176939381 [GRCh37] Chr5:5q35.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_016222.4(DDX41):c.1415C>T (p.Thr472Ile) | single nucleotide variant | not provided [RCV003325772] | Chr5:177512630 [GRCh38] Chr5:176939631 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.694A>G (p.Thr232Ala) | single nucleotide variant | not provided [RCV003332559] | Chr5:177515020 [GRCh38] Chr5:176942021 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.952G>A (p.Val318Met) | single nucleotide variant | Inborn genetic diseases [RCV003367106] | Chr5:177513831 [GRCh38] Chr5:176940832 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1259A>G (p.Lys420Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003459957] | Chr5:177513054 [GRCh38] Chr5:176940055 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.844C>T (p.Arg282Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003475579]|not provided [RCV003779009] | Chr5:177514792 [GRCh38] Chr5:176941793 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1836G>A (p.Lys612=) | single nucleotide variant | not provided [RCV003569916] | Chr5:177511824 [GRCh38] Chr5:176938825 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.723G>T (p.Met241Ile) | single nucleotide variant | not provided [RCV003543248] | Chr5:177514991 [GRCh38] Chr5:176941992 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1110G>A (p.Gln370=) | single nucleotide variant | DDX41-related disorder [RCV003909046]|not provided [RCV003570718] | Chr5:177513473 [GRCh38] Chr5:176940474 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1400-16G>A | single nucleotide variant | not provided [RCV003570287] | Chr5:177512661 [GRCh38] Chr5:176939662 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.88G>A (p.Asp30Asn) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466134] | Chr5:177516775 [GRCh38] Chr5:176943776 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.883G>A (p.Ala295Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466135]|not provided [RCV003553948] | Chr5:177514753 [GRCh38] Chr5:176941754 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.410C>T (p.Thr137Met) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466137]|not provided [RCV003661058] | Chr5:177515953 [GRCh38] Chr5:176942954 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.207A>C (p.Glu69Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466153] | Chr5:177516379 [GRCh38] Chr5:176943380 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.935+1G>T | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466160] | Chr5:177514700 [GRCh38] Chr5:176941701 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1428G>T (p.Glu476Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466133] | Chr5:177512617 [GRCh38] Chr5:176939618 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.68C>T (p.Ser23Phe) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466152]|not provided [RCV004763693] | Chr5:177516795 [GRCh38] Chr5:176943796 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.575del (p.Ile192fs) | deletion | DDX41-related disorder [RCV003908981]|DDX41-related hematologic malignancy predisposition syndrome [RCV003466159] | Chr5:177515255 [GRCh38] Chr5:176942256 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
Single allele | deletion | not provided [RCV003448669] | Chr5:175559209..177430432 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.2-35.3(chr5:175332333-177469711)x1 | copy number loss | not provided [RCV003485494] | Chr5:175332333..177469711 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.22C>T (p.Arg8Trp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466138] | Chr5:177516924 [GRCh38] Chr5:176943925 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1494C>A (p.Phe498Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466142] | Chr5:177512551 [GRCh38] Chr5:176939552 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.214G>A (p.Gly72Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466143] | Chr5:177516372 [GRCh38] Chr5:176943373 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.108T>A (p.Tyr36Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466155] | Chr5:177516755 [GRCh38] Chr5:176943756 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.362C>T (p.Ala121Val) | single nucleotide variant | DDX41-related disorder [RCV003391268] | Chr5:177516130 [GRCh38] Chr5:176943131 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.845G>A (p.Arg282His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466147] | Chr5:177514791 [GRCh38] Chr5:176941792 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.204T>G (p.Ser68Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466150] | Chr5:177516382 [GRCh38] Chr5:176943383 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.13G>T (p.Glu5Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466161] | Chr5:177516933 [GRCh38] Chr5:176943934 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.722T>C (p.Met241Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466146] | Chr5:177514992 [GRCh38] Chr5:176941993 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1496del (p.Pro499fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV003466158]|not provided [RCV003553949] | Chr5:177512549 [GRCh38] Chr5:176939550 [GRCh37] Chr5:5q35.3 |
pathogenic|likely pathogenic |
NM_016222.4(DDX41):c.583G>C (p.Gly195Arg) | single nucleotide variant | DDX41-related disorder [RCV003400154] | Chr5:177515247 [GRCh38] Chr5:176942248 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.853C>G (p.Gln285Glu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003459958] | Chr5:177514783 [GRCh38] Chr5:176941784 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.748T>G (p.Leu250Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003459956]|not provided [RCV003661057] | Chr5:177514966 [GRCh38] Chr5:176941967 [GRCh37] Chr5:5q35.3 |
likely benign|uncertain significance |
NM_016222.4(DDX41):c.963G>A (p.Pro321=) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466136]|not provided [RCV003779008] | Chr5:177513820 [GRCh38] Chr5:176940821 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.900C>T (p.Gly300=) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466140] | Chr5:177514736 [GRCh38] Chr5:176941737 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27G>A (p.Lys9=) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466145] | Chr5:177516919 [GRCh38] Chr5:176943920 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.712C>T (p.Pro238Ser) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466154] | Chr5:177515002 [GRCh38] Chr5:176942003 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.55G>T (p.Gly19Ter) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466157] | Chr5:177516808 [GRCh38] Chr5:176943809 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1542_1543del (p.Asn515fs) | microsatellite | DDX41-related disorder [RCV003408555] | Chr5:177512502..177512503 [GRCh38] Chr5:176939503..176939504 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1850A>G (p.His617Arg) | single nucleotide variant | DDX41-related disorder [RCV003414238]|DDX41-related hematologic malignancy predisposition syndrome [RCV003459854] | Chr5:177511810 [GRCh38] Chr5:176938811 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.968G>A (p.Arg323His) | single nucleotide variant | not provided [RCV003442599] | Chr5:177513815 [GRCh38] Chr5:176940816 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1203T>G (p.Ala401=) | single nucleotide variant | not provided [RCV003430032] | Chr5:177513380 [GRCh38] Chr5:176940381 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.940G>A (p.Val314Ile) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466144]|not provided [RCV003720914] | Chr5:177513843 [GRCh38] Chr5:176940844 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1309A>G (p.Ile437Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466148]|not provided [RCV004765843] | Chr5:177512870 [GRCh38] Chr5:176939871 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.255C>G (p.Val85=) | single nucleotide variant | DDX41-related disorder [RCV003410396]|DDX41-related hematologic malignancy predisposition syndrome [RCV004572973] | Chr5:177516331 [GRCh38] Chr5:176943332 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.844C>G (p.Arg282Gly) | single nucleotide variant | not provided [RCV003441408] | Chr5:177514792 [GRCh38] Chr5:176941793 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.902T>C (p.Met301Thr) | single nucleotide variant | not provided [RCV003441369] | Chr5:177514734 [GRCh38] Chr5:176941735 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1423A>T (p.Ile475Phe) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466139] | Chr5:177512622 [GRCh38] Chr5:176939623 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.632G>A (p.Gly211Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV003466151] | Chr5:177515198 [GRCh38] Chr5:176942199 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.208C>T (p.Pro70Ser) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004572977]|not provided [RCV003442718] | Chr5:177516378 [GRCh38] Chr5:176943379 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.708G>A (p.Thr236=) | single nucleotide variant | not provided [RCV003831915] | Chr5:177515006 [GRCh38] Chr5:176942007 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1599T>G (p.Thr533=) | single nucleotide variant | not provided [RCV003660105] | Chr5:177512344 [GRCh38] Chr5:176939345 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.562T>A (p.Phe188Ile) | single nucleotide variant | not provided [RCV003695468] | Chr5:177515694 [GRCh38] Chr5:176942695 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1399+18A>T | single nucleotide variant | not provided [RCV003881505] | Chr5:177512762 [GRCh38] Chr5:176939763 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.27+9G>C | single nucleotide variant | not provided [RCV003828354] | Chr5:177516910 [GRCh38] Chr5:176943911 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.299-15C>G | single nucleotide variant | not provided [RCV003579411] | Chr5:177516208 [GRCh38] Chr5:176943209 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1167C>A (p.Ala389=) | single nucleotide variant | not provided [RCV003830014] | Chr5:177513416 [GRCh38] Chr5:176940417 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.935+9T>G | single nucleotide variant | DDX41-related disorder [RCV003893378]|not provided [RCV003739418] | Chr5:177514692 [GRCh38] Chr5:176941693 [GRCh37] Chr5:5q35.3 |
benign|likely benign |
NM_016222.4(DDX41):c.435-18C>A | single nucleotide variant | not provided [RCV003712809] | Chr5:177515839 [GRCh38] Chr5:176942840 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.644+10G>T | single nucleotide variant | not provided [RCV003828874] | Chr5:177515176 [GRCh38] Chr5:176942177 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.438G>A (p.Trp146Ter) | single nucleotide variant | not provided [RCV003547017] | Chr5:177515818 [GRCh38] Chr5:176942819 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1732+6T>G | single nucleotide variant | not provided [RCV003715755] | Chr5:177512090 [GRCh38] Chr5:176939091 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1565G>A (p.Arg522His) | single nucleotide variant | not provided [RCV003875986] | Chr5:177512378 [GRCh38] Chr5:176939379 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.966G>T (p.Gly322=) | single nucleotide variant | not provided [RCV003573668] | Chr5:177513817 [GRCh38] Chr5:176940818 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1231-14del | deletion | not provided [RCV003692521] | Chr5:177513096 [GRCh38] Chr5:176940097 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1273C>T (p.Leu425Phe) | single nucleotide variant | not provided [RCV003572925] | Chr5:177513040 [GRCh38] Chr5:176940041 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1303-3C>T | single nucleotide variant | not provided [RCV003662112] | Chr5:177512879 [GRCh38] Chr5:176939880 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.486C>T (p.Arg162=) | single nucleotide variant | not provided [RCV003739330] | Chr5:177515770 [GRCh38] Chr5:176942771 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1441G>A (p.Gly481Ser) | single nucleotide variant | not provided [RCV003660119] | Chr5:177512604 [GRCh38] Chr5:176939605 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1550-4G>C | single nucleotide variant | not provided [RCV003572135] | Chr5:177512397 [GRCh38] Chr5:176939398 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.645-15A>T | single nucleotide variant | not provided [RCV003572582] | Chr5:177515084 [GRCh38] Chr5:176942085 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.43G>C (p.Glu15Gln) | single nucleotide variant | not provided [RCV003545343] | Chr5:177516820 [GRCh38] Chr5:176943821 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.920T>G (p.Met307Arg) | single nucleotide variant | not provided [RCV003545884] | Chr5:177514716 [GRCh38] Chr5:176941717 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.859G>A (p.Asp287Asn) | single nucleotide variant | not provided [RCV003575496] | Chr5:177514777 [GRCh38] Chr5:176941778 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1303-7C>T | single nucleotide variant | not provided [RCV003575626] | Chr5:177512883 [GRCh38] Chr5:176939884 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1680G>A (p.Pro560=) | single nucleotide variant | not provided [RCV003876747] | Chr5:177512148 [GRCh38] Chr5:176939149 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1854C>T (p.Ser618=) | single nucleotide variant | not provided [RCV003714963] | Chr5:177511806 [GRCh38] Chr5:176938807 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1549+19A>G | single nucleotide variant | not provided [RCV003688811] | Chr5:177512477 [GRCh38] Chr5:176939478 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.409dup (p.Thr137fs) | duplication | not provided [RCV003660073] | Chr5:177515953..177515954 [GRCh38] Chr5:176942954..176942955 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.1062C>T (p.Phe354=) | single nucleotide variant | not provided [RCV003826536] | Chr5:177513721 [GRCh38] Chr5:176940722 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.546C>T (p.Ser182=) | single nucleotide variant | not provided [RCV003691796] | Chr5:177515710 [GRCh38] Chr5:176942711 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.901A>G (p.Met301Val) | single nucleotide variant | not provided [RCV003693843] | Chr5:177514735 [GRCh38] Chr5:176941736 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.800G>A (p.Arg267Gln) | single nucleotide variant | not provided [RCV003739471] | Chr5:177514836 [GRCh38] Chr5:176941837 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.164G>T (p.Arg55Leu) | single nucleotide variant | not provided [RCV003878622] | Chr5:177516422 [GRCh38] Chr5:176943423 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.952G>T (p.Val318Leu) | single nucleotide variant | not provided [RCV003739762] | Chr5:177513831 [GRCh38] Chr5:176940832 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1298C>T (p.Pro433Leu) | single nucleotide variant | not provided [RCV003696246] | Chr5:177513015 [GRCh38] Chr5:176940016 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1570G>A (p.Gly524Arg) | single nucleotide variant | not provided [RCV003687302] | Chr5:177512373 [GRCh38] Chr5:176939374 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1338C>T (p.Asp446=) | single nucleotide variant | not provided [RCV003826676] | Chr5:177512841 [GRCh38] Chr5:176939842 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.374-8C>G | single nucleotide variant | not provided [RCV003572610] | Chr5:177515997 [GRCh38] Chr5:176942998 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.752C>T (p.Pro251Leu) | single nucleotide variant | not provided [RCV003827658] | Chr5:177514962 [GRCh38] Chr5:176941963 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.298+19C>G | single nucleotide variant | not provided [RCV003878147] | Chr5:177516269 [GRCh38] Chr5:176943270 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1585A>G (p.Thr529Ala) | single nucleotide variant | not provided [RCV003663568] | Chr5:177512358 [GRCh38] Chr5:176939359 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.24G>T (p.Arg8=) | single nucleotide variant | not provided [RCV003579717] | Chr5:177516922 [GRCh38] Chr5:176943923 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.28-5T>C | single nucleotide variant | not provided [RCV003698002] | Chr5:177516840 [GRCh38] Chr5:176943841 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.584G>T (p.Gly195Val) | single nucleotide variant | not provided [RCV003580825] | Chr5:177515246 [GRCh38] Chr5:176942247 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.373+1G>A | single nucleotide variant | not provided [RCV003580974] | Chr5:177516118 [GRCh38] Chr5:176943119 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1538T>C (p.Ile513Thr) | single nucleotide variant | not provided [RCV003697256] | Chr5:177512507 [GRCh38] Chr5:176939508 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.753C>A (p.Pro251=) | single nucleotide variant | not provided [RCV003832474] | Chr5:177514961 [GRCh38] Chr5:176941962 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1099-16C>G | single nucleotide variant | not provided [RCV003851958] | Chr5:177513500 [GRCh38] Chr5:176940501 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.258C>T (p.Ser86=) | single nucleotide variant | not provided [RCV003665151] | Chr5:177516328 [GRCh38] Chr5:176943329 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.588G>C (p.Leu196=) | single nucleotide variant | not provided [RCV003703020] | Chr5:177515242 [GRCh38] Chr5:176942243 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.645-20G>C | single nucleotide variant | not provided [RCV003811825] | Chr5:177515089 [GRCh38] Chr5:176942090 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.456T>A (p.Val152=) | single nucleotide variant | DDX41-related disorder [RCV003949048]|not provided [RCV003838375] | Chr5:177515800 [GRCh38] Chr5:176942801 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.451T>C (p.Tyr151His) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004573254]|not provided [RCV003717240] | Chr5:177515805 [GRCh38] Chr5:176942806 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.892A>G (p.Ile298Val) | single nucleotide variant | not provided [RCV003666113] | Chr5:177514744 [GRCh38] Chr5:176941745 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.919A>G (p.Met307Val) | single nucleotide variant | not provided [RCV003669460] | Chr5:177514717 [GRCh38] Chr5:176941718 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.138+13C>T | single nucleotide variant | not provided [RCV003832790] | Chr5:177516712 [GRCh38] Chr5:176943713 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1621+6T>C | single nucleotide variant | not provided [RCV003850251] | Chr5:177512316 [GRCh38] Chr5:176939317 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.789C>T (p.Ile263=) | single nucleotide variant | not provided [RCV003725933] | Chr5:177514925 [GRCh38] Chr5:176941926 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.435-8A>C | single nucleotide variant | DDX41-related disorder [RCV003939220]|not provided [RCV003833013] | Chr5:177515829 [GRCh38] Chr5:176942830 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1167C>T (p.Ala389=) | single nucleotide variant | not provided [RCV003558986] | Chr5:177513416 [GRCh38] Chr5:176940417 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1242T>C (p.Tyr414=) | single nucleotide variant | not provided [RCV003816723] | Chr5:177513071 [GRCh38] Chr5:176940072 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.373+4T>C | single nucleotide variant | not provided [RCV003856567] | Chr5:177516115 [GRCh38] Chr5:176943116 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.104C>T (p.Pro35Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004574197]|not provided [RCV003673284] | Chr5:177516759 [GRCh38] Chr5:176943760 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1224C>T (p.Val408=) | single nucleotide variant | not provided [RCV003855530] | Chr5:177513359 [GRCh38] Chr5:176940360 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.19G>C (p.Glu7Gln) | single nucleotide variant | not provided [RCV003560565] | Chr5:177516927 [GRCh38] Chr5:176943928 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1099-11del | deletion | not provided [RCV003851957] | Chr5:177513495 [GRCh38] Chr5:176940496 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.104C>G (p.Pro35Arg) | single nucleotide variant | not provided [RCV003839923] | Chr5:177516759 [GRCh38] Chr5:176943760 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.571+14G>A | single nucleotide variant | not provided [RCV003673602] | Chr5:177515671 [GRCh38] Chr5:176942672 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+16G>A | single nucleotide variant | not provided [RCV003816265] | Chr5:177513669 [GRCh38] Chr5:176940670 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1733-20C>T | single nucleotide variant | not provided [RCV003667445] | Chr5:177511947 [GRCh38] Chr5:176938948 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.507C>T (p.Ile169=) | single nucleotide variant | not provided [RCV003838234] | Chr5:177515749 [GRCh38] Chr5:176942750 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1231-20C>T | single nucleotide variant | not provided [RCV003816324] | Chr5:177513102 [GRCh38] Chr5:176940103 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.27+11G>A | single nucleotide variant | not provided [RCV003854799] | Chr5:177516908 [GRCh38] Chr5:176943909 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1060T>C (p.Phe354Leu) | single nucleotide variant | not provided [RCV003666059] | Chr5:177513723 [GRCh38] Chr5:176940724 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.337G>A (p.Glu113Lys) | single nucleotide variant | not provided [RCV003558321] | Chr5:177516155 [GRCh38] Chr5:176943156 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+1G>A | single nucleotide variant | not provided [RCV003816352] | Chr5:177516918 [GRCh38] Chr5:176943919 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.292G>A (p.Ala98Thr) | single nucleotide variant | not provided [RCV003666940] | Chr5:177516294 [GRCh38] Chr5:176943295 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.681G>T (p.Thr227=) | single nucleotide variant | not provided [RCV003667029] | Chr5:177515033 [GRCh38] Chr5:176942034 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1644C>T (p.Leu548=) | single nucleotide variant | DDX41-related disorder [RCV003909000]|not provided [RCV003548079] | Chr5:177512184 [GRCh38] Chr5:176939185 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1225A>G (p.Ile409Val) | single nucleotide variant | not provided [RCV003854473] | Chr5:177513358 [GRCh38] Chr5:176940359 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.405C>T (p.Gly135=) | single nucleotide variant | not provided [RCV003667754] | Chr5:177515958 [GRCh38] Chr5:176942959 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1732+14G>A | single nucleotide variant | not provided [RCV003697946] | Chr5:177512082 [GRCh38] Chr5:176939083 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.163C>T (p.Arg55Cys) | single nucleotide variant | not provided [RCV003835521] | Chr5:177516423 [GRCh38] Chr5:176943424 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1303-17T>G | single nucleotide variant | not provided [RCV003850172] | Chr5:177512893 [GRCh38] Chr5:176939894 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.16C>A (p.Pro6Thr) | single nucleotide variant | not provided [RCV003852268] | Chr5:177516930 [GRCh38] Chr5:176943931 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1794C>T (p.Leu598=) | single nucleotide variant | not provided [RCV003814621] | Chr5:177511866 [GRCh38] Chr5:176938867 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.139-16C>T | single nucleotide variant | not provided [RCV003672362] | Chr5:177516463 [GRCh38] Chr5:176943464 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.434+13A>G | single nucleotide variant | not provided [RCV003834835] | Chr5:177515916 [GRCh38] Chr5:176942917 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.572-15G>A | single nucleotide variant | not provided [RCV003668348] | Chr5:177515273 [GRCh38] Chr5:176942274 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+13C>T | single nucleotide variant | not provided [RCV003663928] | Chr5:177516906 [GRCh38] Chr5:176943907 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1099-12C>G | single nucleotide variant | not provided [RCV003665632] | Chr5:177513496 [GRCh38] Chr5:176940497 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.487G>A (p.Val163Met) | single nucleotide variant | not provided [RCV003818562] | Chr5:177515769 [GRCh38] Chr5:176942770 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.374-17C>T | single nucleotide variant | not provided [RCV003823181] | Chr5:177516006 [GRCh38] Chr5:176943007 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.769G>C (p.Gly257Arg) | single nucleotide variant | not provided [RCV003711155] | Chr5:177514945 [GRCh38] Chr5:176941946 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1733-17del | deletion | not provided [RCV003857928] | Chr5:177511944 [GRCh38] Chr5:176938945 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.374-16A>G | single nucleotide variant | not provided [RCV003844664] | Chr5:177516005 [GRCh38] Chr5:176943006 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.374-15T>C | single nucleotide variant | not provided [RCV003860170] | Chr5:177516004 [GRCh38] Chr5:176943005 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1231-18T>C | single nucleotide variant | not provided [RCV003711243] | Chr5:177513100 [GRCh38] Chr5:176940101 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.139C>T (p.Leu47Phe) | single nucleotide variant | not provided [RCV003857411] | Chr5:177516447 [GRCh38] Chr5:176943448 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1868G>A (p.Ter623=) | single nucleotide variant | not provided [RCV003682942] | Chr5:177511792 [GRCh38] Chr5:176938793 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1679C>T (p.Pro560Leu) | single nucleotide variant | not provided [RCV003675082] | Chr5:177512149 [GRCh38] Chr5:176939150 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+19C>T | single nucleotide variant | not provided [RCV003822618] | Chr5:177516900 [GRCh38] Chr5:176943901 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.27+17A>C | single nucleotide variant | not provided [RCV003845247] | Chr5:177516902 [GRCh38] Chr5:176943903 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1740C>T (p.Arg580=) | single nucleotide variant | not provided [RCV003821716] | Chr5:177511920 [GRCh38] Chr5:176938921 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1026C>G (p.Ala342=) | single nucleotide variant | not provided [RCV003864396] | Chr5:177513757 [GRCh38] Chr5:176940758 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.726C>G (p.Phe242Leu) | single nucleotide variant | not provided [RCV003734121] | Chr5:177514988 [GRCh38] Chr5:176941989 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.298+8G>A | single nucleotide variant | DDX41-related disorder [RCV003966530]|not provided [RCV003568341] | Chr5:177516280 [GRCh38] Chr5:176943281 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.645-8C>T | single nucleotide variant | DDX41-related disorder [RCV003984406]|not provided [RCV003682557] | Chr5:177515077 [GRCh38] Chr5:176942078 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.373+15A>G | single nucleotide variant | not provided [RCV003706334] | Chr5:177516104 [GRCh38] Chr5:176943105 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.562T>C (p.Phe188Leu) | single nucleotide variant | not provided [RCV003563956] | Chr5:177515694 [GRCh38] Chr5:176942695 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.457C>A (p.Leu153Met) | single nucleotide variant | not provided [RCV003681695] | Chr5:177515799 [GRCh38] Chr5:176942800 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.299-10_299-8del | microsatellite | not provided [RCV003734393] | Chr5:177516201..177516203 [GRCh38] Chr5:176943202..176943204 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.504C>T (p.His168=) | single nucleotide variant | not provided [RCV003682522] | Chr5:177515752 [GRCh38] Chr5:176942753 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.23G>T (p.Arg8Leu) | single nucleotide variant | not provided [RCV003678462] | Chr5:177516923 [GRCh38] Chr5:176943924 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.608A>G (p.His203Arg) | single nucleotide variant | not provided [RCV003858183] | Chr5:177515222 [GRCh38] Chr5:176942223 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.930C>T (p.Ile310=) | single nucleotide variant | not provided [RCV003568609] | Chr5:177514706 [GRCh38] Chr5:176941707 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.801G>T (p.Arg267=) | single nucleotide variant | not provided [RCV003865779] | Chr5:177514835 [GRCh38] Chr5:176941836 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+11del | deletion | not provided [RCV003866938] | Chr5:177513674 [GRCh38] Chr5:176940675 [GRCh37] Chr5:5q35.3 |
benign |
NM_016222.4(DDX41):c.1465A>G (p.Thr489Ala) | single nucleotide variant | not provided [RCV003683911] | Chr5:177512580 [GRCh38] Chr5:176939581 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.302G>A (p.Arg101His) | single nucleotide variant | not provided [RCV003706646] | Chr5:177516190 [GRCh38] Chr5:176943191 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+3A>C | single nucleotide variant | not provided [RCV003705360] | Chr5:177516916 [GRCh38] Chr5:176943917 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1368G>C (p.Gly456=) | single nucleotide variant | not provided [RCV003842411] | Chr5:177512811 [GRCh38] Chr5:176939812 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.937G>C (p.Gly313Arg) | single nucleotide variant | not provided [RCV003736032] | Chr5:177513846 [GRCh38] Chr5:176940847 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.367G>A (p.Gly123Ser) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004573373]|not provided [RCV003869822] | Chr5:177516125 [GRCh38] Chr5:176943126 [GRCh37] Chr5:5q35.3 |
uncertain significance |
GRCh37/hg19 5q35.2-35.3(chr5:176385815-178410738)x1 | copy number loss | not specified [RCV003986570] | Chr5:176385815..178410738 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
GRCh37/hg19 5q35.3(chr5:176744569-177107777)x3 | copy number gain | not specified [RCV003986576] | Chr5:176744569..177107777 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.944A>C (p.His315Pro) | single nucleotide variant | not provided [RCV003565802] | Chr5:177513839 [GRCh38] Chr5:176940840 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.261C>G (p.Leu87=) | single nucleotide variant | not provided [RCV003721763] | Chr5:177516325 [GRCh38] Chr5:176943326 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1014_1023del (p.Cys338fs) | deletion | not provided [RCV003685421] | Chr5:177513760..177513769 [GRCh38] Chr5:176940761..176940770 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.572-16C>T | single nucleotide variant | not provided [RCV003860857] | Chr5:177515274 [GRCh38] Chr5:176942275 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1018T>C (p.Tyr340His) | single nucleotide variant | not provided [RCV003720990] | Chr5:177513765 [GRCh38] Chr5:176940766 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.154C>T (p.Gln52Ter) | single nucleotide variant | DDX41-related disorder [RCV003941362] | Chr5:177516432 [GRCh38] Chr5:176943433 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.374-12C>T | single nucleotide variant | not provided [RCV003821940] | Chr5:177516001 [GRCh38] Chr5:176943002 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.139-12G>C | single nucleotide variant | not provided [RCV003867169] | Chr5:177516459 [GRCh38] Chr5:176943460 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.645-20G>A | single nucleotide variant | not provided [RCV003721519] | Chr5:177515089 [GRCh38] Chr5:176942090 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1266G>A (p.Val422=) | single nucleotide variant | not provided [RCV003722763] | Chr5:177513047 [GRCh38] Chr5:176940048 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1063G>A (p.Glu355Lys) | single nucleotide variant | not provided [RCV003737264] | Chr5:177513720 [GRCh38] Chr5:176940721 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1154_1155del (p.Phe385fs) | deletion | not provided [RCV003870085] | Chr5:177513428..177513429 [GRCh38] Chr5:176940429..176940430 [GRCh37] Chr5:5q35.3 |
pathogenic |
NM_016222.4(DDX41):c.583G>A (p.Gly195Ser) | single nucleotide variant | not provided [RCV003722962] | Chr5:177515247 [GRCh38] Chr5:176942248 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1230G>A (p.Gln410=) | single nucleotide variant | not provided [RCV003685443] | Chr5:177513353 [GRCh38] Chr5:176940354 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.248C>T (p.Ser83Phe) | single nucleotide variant | not provided [RCV003841133] | Chr5:177516338 [GRCh38] Chr5:176943339 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.265G>A (p.Asp89Asn) | single nucleotide variant | not provided [RCV003679702] | Chr5:177516321 [GRCh38] Chr5:176943322 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.783C>T (p.Leu261=) | single nucleotide variant | not provided [RCV003853160] | Chr5:177514931 [GRCh38] Chr5:176941932 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.893T>C (p.Ile298Thr) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004574260]|not provided [RCV003709035] | Chr5:177514743 [GRCh38] Chr5:176941744 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1550-11_1550-9del | deletion | not provided [RCV003845623] | Chr5:177512402..177512404 [GRCh38] Chr5:176939403..176939405 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.373+19T>C | single nucleotide variant | not provided [RCV003819150] | Chr5:177516100 [GRCh38] Chr5:176943101 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.50C>G (p.Pro17Arg) | single nucleotide variant | not provided [RCV003565887] | Chr5:177516813 [GRCh38] Chr5:176943814 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.434+3A>G | single nucleotide variant | not provided [RCV003841771] | Chr5:177515926 [GRCh38] Chr5:176942927 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.146A>G (p.Lys49Arg) | single nucleotide variant | not provided [RCV003567494] | Chr5:177516440 [GRCh38] Chr5:176943441 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.808G>A (p.Ala270Thr) | single nucleotide variant | not provided [RCV003551802] | Chr5:177514828 [GRCh38] Chr5:176941829 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.298+13_298+14delinsAT | indel | not provided [RCV003857184] | Chr5:177516274..177516275 [GRCh38] Chr5:176943275..176943276 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.945C>T (p.His315=) | single nucleotide variant | not provided [RCV003562497] | Chr5:177513838 [GRCh38] Chr5:176940839 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1254G>A (p.Glu418=) | single nucleotide variant | not provided [RCV003728530] | Chr5:177513059 [GRCh38] Chr5:176940060 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.434+12C>G | single nucleotide variant | not provided [RCV003563571] | Chr5:177515917 [GRCh38] Chr5:176942918 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.75G>A (p.Ala25=) | single nucleotide variant | not provided [RCV003565123] | Chr5:177516788 [GRCh38] Chr5:176943789 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.435-19C>T | single nucleotide variant | not provided [RCV003681568] | Chr5:177515840 [GRCh38] Chr5:176942841 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.774C>T (p.Pro258=) | single nucleotide variant | not provided [RCV003864635] | Chr5:177514940 [GRCh38] Chr5:176941941 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.135A>C (p.Leu45=) | single nucleotide variant | not provided [RCV003819985] | Chr5:177516728 [GRCh38] Chr5:176943729 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.464T>C (p.Met155Thr) | single nucleotide variant | not provided [RCV003859998] | Chr5:177515792 [GRCh38] Chr5:176942793 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.876G>A (p.Leu292=) | single nucleotide variant | not provided [RCV003822847] | Chr5:177514760 [GRCh38] Chr5:176941761 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.524G>A (p.Gly175Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004573272]|not provided [RCV003734482] | Chr5:177515732 [GRCh38] Chr5:176942733 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.753C>T (p.Pro251=) | single nucleotide variant | not provided [RCV003554168] | Chr5:177514961 [GRCh38] Chr5:176941962 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1098+12G>C | single nucleotide variant | not provided [RCV003820408] | Chr5:177513673 [GRCh38] Chr5:176940674 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.763C>T (p.Arg255Cys) | single nucleotide variant | not provided [RCV003705911] | Chr5:177514951 [GRCh38] Chr5:176941952 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1593C>T (p.Ile531=) | single nucleotide variant | DDX41-related disorder [RCV003954622] | Chr5:177512350 [GRCh38] Chr5:176939351 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.*1G>A | single nucleotide variant | DDX41-related disorder [RCV003969608] | Chr5:177511790 [GRCh38] Chr5:176938791 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1302+3G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003988814] | Chr5:177513008 [GRCh38] Chr5:176940009 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.714C>T (p.Pro238=) | single nucleotide variant | DDX41-related disorder [RCV003983665] | Chr5:177515000 [GRCh38] Chr5:176942001 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.627C>T (p.Ile209=) | single nucleotide variant | DDX41-related disorder [RCV003896383] | Chr5:177515203 [GRCh38] Chr5:176942204 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.212G>A (p.Arg71Gln) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004573459]|Inborn genetic diseases [RCV004375826] | Chr5:177516374 [GRCh38] Chr5:176943375 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1668G>A (p.Lys556=) | single nucleotide variant | DDX41-related disorder [RCV003981731] | Chr5:177512160 [GRCh38] Chr5:176939161 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1230+8G>A | single nucleotide variant | DDX41-related disorder [RCV003963991] | Chr5:177513345 [GRCh38] Chr5:176940346 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.28-10G>C | single nucleotide variant | DDX41-related disorder [RCV003963947] | Chr5:177516845 [GRCh38] Chr5:176943846 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1585A>C (p.Thr529Pro) | single nucleotide variant | DDX41-related disorder [RCV003921753] | Chr5:177512358 [GRCh38] Chr5:176939359 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.435-9C>T | single nucleotide variant | DDX41-related disorder [RCV003894246] | Chr5:177515830 [GRCh38] Chr5:176942831 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1510G>A (p.Val504Ile) | single nucleotide variant | DDX41-related disorder [RCV003982801]|DDX41-related hematologic malignancy predisposition syndrome [RCV004573448] | Chr5:177512535 [GRCh38] Chr5:176939536 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.298+8G>T | single nucleotide variant | DDX41-related disorder [RCV003954444] | Chr5:177516280 [GRCh38] Chr5:176943281 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.192G>A (p.Gln64=) | single nucleotide variant | DDX41-related disorder [RCV003899763] | Chr5:177516394 [GRCh38] Chr5:176943395 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.508C>T (p.Leu170=) | single nucleotide variant | DDX41-related disorder [RCV003921836] | Chr5:177515748 [GRCh38] Chr5:176942749 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.572-5C>T | single nucleotide variant | DDX41-related disorder [RCV003944741] | Chr5:177515263 [GRCh38] Chr5:176942264 [GRCh37] Chr5:5q35.3 |
likely benign |
GRCh37/hg19 5q35.2-35.3(chr5:175470000-177450000)x1 | copy number loss | not provided [RCV004577486] | Chr5:175470000..177450000 [GRCh37] Chr5:5q35.2-35.3 |
pathogenic |
NM_016222.4(DDX41):c.1622-3C>A | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575800] | Chr5:177512209 [GRCh38] Chr5:176939210 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NC_000005.9:g.(?_176936891)_(176939413_?)del | deletion | not provided [RCV004580632] | Chr5:176936891..176939413 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.798G>A (p.Ser266=) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575779] | Chr5:177514916 [GRCh38] Chr5:176941917 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.400A>G (p.Lys134Glu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575780] | Chr5:177515963 [GRCh38] Chr5:176942964 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.751C>G (p.Pro251Ala) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575781] | Chr5:177514963 [GRCh38] Chr5:176941964 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.739G>A (p.Glu247Lys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575782] | Chr5:177514975 [GRCh38] Chr5:176941976 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.89A>C (p.Asp30Ala) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575783] | Chr5:177516774 [GRCh38] Chr5:176943775 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.938G>A (p.Gly313Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575784]|not provided [RCV004775580] | Chr5:177513845 [GRCh38] Chr5:176940846 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.741G>C (p.Glu247Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575785] | Chr5:177514973 [GRCh38] Chr5:176941974 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1168C>T (p.Leu390Phe) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575786] | Chr5:177513415 [GRCh38] Chr5:176940416 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.72G>C (p.Glu24Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575787] | Chr5:177516791 [GRCh38] Chr5:176943792 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1159A>C (p.Lys387Gln) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575788] | Chr5:177513424 [GRCh38] Chr5:176940425 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.223G>A (p.Asp75Asn) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575789] | Chr5:177516363 [GRCh38] Chr5:176943364 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.299-3C>A | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575790] | Chr5:177516196 [GRCh38] Chr5:176943197 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1042C>T (p.Arg348Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575791] | Chr5:177513741 [GRCh38] Chr5:176940742 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.4G>C (p.Glu2Gln) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575792] | Chr5:177516942 [GRCh38] Chr5:176943943 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.458T>G (p.Leu153Arg) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575793] | Chr5:177515798 [GRCh38] Chr5:176942799 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.1435C>T (p.Arg479Trp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575794]|not provided [RCV004588568] | Chr5:177512610 [GRCh38] Chr5:176939611 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.448C>T (p.Arg150Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575795] | Chr5:177515808 [GRCh38] Chr5:176942809 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.797C>T (p.Ser266Leu) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575796] | Chr5:177514917 [GRCh38] Chr5:176941918 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.435-6C>G | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575797] | Chr5:177515827 [GRCh38] Chr5:176942828 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.839A>G (p.Tyr280Cys) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575798] | Chr5:177514797 [GRCh38] Chr5:176941798 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.881G>T (p.Cys294Phe) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575799] | Chr5:177514755 [GRCh38] Chr5:176941756 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.524G>T (p.Gly175Val) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004575801] | Chr5:177515732 [GRCh38] Chr5:176942733 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.520G>A (p.Asp174Asn) | single nucleotide variant | not provided [RCV004762670] | uncertain significance | |
NM_016222.4(DDX41):c.943C>T (p.His315Tyr) | single nucleotide variant | not provided [RCV004771370] | Chr5:177513840 [GRCh38] Chr5:176940841 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.47_48del (p.Val16fs) | deletion | DDX41-related hematologic malignancy predisposition syndrome [RCV004764595] | Chr5:177516815..177516816 [GRCh38] Chr5:176943816..176943817 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.1628C>G (p.Ser543Ter) | single nucleotide variant | not provided [RCV004729254] | Chr5:177512200 [GRCh38] Chr5:176939201 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.972C>T (p.Leu324=) | single nucleotide variant | not provided [RCV004762619] | uncertain significance | |
NM_016222.4(DDX41):c.1682C>T (p.Pro561Leu) | single nucleotide variant | not provided [RCV004775821] | Chr5:177512146 [GRCh38] Chr5:176939147 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.672C>T (p.Ile224=) | single nucleotide variant | not provided [RCV004772421] | Chr5:177515042 [GRCh38] Chr5:176942043 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.27+4_27+5del | deletion | not provided [RCV004763132] | uncertain significance | |
NM_016222.4(DDX41):c.571+7_571+8del | deletion | not provided [RCV004767834] | Chr5:177515677..177515678 [GRCh38] Chr5:176942678..176942679 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1230+3G>T | single nucleotide variant | DDX41-related disorder [RCV004752390] | Chr5:177513350 [GRCh38] Chr5:176940351 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1154T>G (p.Phe385Cys) | single nucleotide variant | not provided [RCV004760821] | uncertain significance | |
NM_016222.4(DDX41):c.1542G>C (p.Glu514Asp) | single nucleotide variant | DDX41-related hematologic malignancy predisposition syndrome [RCV004759579] | uncertain significance | |
NM_016222.4(DDX41):c.568G>A (p.Ala190Thr) | single nucleotide variant | not provided [RCV004761697] | uncertain significance | |
NM_016222.4(DDX41):c.1222G>A (p.Val408Ile) | single nucleotide variant | not provided [RCV004773989] | Chr5:177513361 [GRCh38] Chr5:176940362 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.936-8G>A | single nucleotide variant | DDX41-related disorder [RCV004730583] | Chr5:177513855 [GRCh38] Chr5:176940856 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.411G>A (p.Thr137=) | single nucleotide variant | DDX41-related disorder [RCV004752236] | Chr5:177515952 [GRCh38] Chr5:176942953 [GRCh37] Chr5:5q35.3 |
likely benign |
NM_016222.4(DDX41):c.1401C>G (p.Asp467Glu) | single nucleotide variant | not provided [RCV004775246] | Chr5:177512644 [GRCh38] Chr5:176939645 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.138+2T>C | single nucleotide variant | DDX41-related disorder [RCV004732201] | Chr5:177516723 [GRCh38] Chr5:176943724 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
NM_016222.4(DDX41):c.728G>A (p.Cys243Tyr) | single nucleotide variant | not provided [RCV004766320] | Chr5:177514986 [GRCh38] Chr5:176941987 [GRCh37] Chr5:5q35.3 |
uncertain significance |
NM_016222.4(DDX41):c.804del (p.Glu268fs) | deletion | not provided [RCV004773602] | Chr5:177514832 [GRCh38] Chr5:176941833 [GRCh37] Chr5:5q35.3 |
likely pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
A002K19 |
|
|||||||||||||||||||||||||||||||||||||||||||||
RH47489 |
|
|||||||||||||||||||||||||||||||||||||||||||||
G16059 |
|
|||||||||||||||||||||||||||||||||||||||||||||
MARC_24355-24356:1030120548:1 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
pharyngeal arch
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
visual system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1204 | 2438 | 2788 | 2252 | 4973 | 1726 | 2351 | 6 | 624 | 1951 | 465 | 2269 | 7304 | 6471 | 53 | 3734 | 1 | 852 | 1744 | 1617 | 175 | 1 |
Ensembl Acc Id: | ENST00000330503 ⟹ ENSP00000330349 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000503078 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000504781 ⟹ ENSP00000425739 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000504807 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000505081 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000506965 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000507900 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000507955 ⟹ ENSP00000422753 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000508279 ⟹ ENSP00000421460 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000509576 ⟹ ENSP00000426330 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000510171 ⟹ ENSP00000427082 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000511040 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000512027 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000512334 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000512431 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000513562 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000515562 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000625286 ⟹ ENSP00000487280 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000629036 ⟹ ENSP00000486367 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000650742 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000652565 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000652618 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000652623 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001321732 ⟹ NP_001308661 | ||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||
Type: | CODING | ||||||||||||||||
Position: |
|
||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001321830 ⟹ NP_001308759 | ||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||
Type: | CODING | ||||||||||||||||
Position: |
|
||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_016222 ⟹ NP_057306 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NP_057306 ⟸ NM_016222 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q9NT96 (UniProtKB/Swiss-Prot), Q96K05 (UniProtKB/Swiss-Prot), Q96BK6 (UniProtKB/Swiss-Prot), B2RDC8 (UniProtKB/Swiss-Prot), Q9NW04 (UniProtKB/Swiss-Prot), Q9UJV9 (UniProtKB/Swiss-Prot), Q53HI2 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001308759 ⟸ NM_001321830 |
- Peptide Label: | isoform 2 |
- UniProtKB: | B3KRK2 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001308661 ⟸ NM_001321732 |
- Peptide Label: | isoform 2 |
- UniProtKB: | B3KRK2 (UniProtKB/TrEMBL) |
- Sequence: |
Ensembl Acc Id: | ENSP00000425739 ⟸ ENST00000504781 |
Ensembl Acc Id: | ENSP00000487280 ⟸ ENST00000625286 |
Ensembl Acc Id: | ENSP00000422753 ⟸ ENST00000507955 |
Ensembl Acc Id: | ENSP00000421460 ⟸ ENST00000508279 |
Ensembl Acc Id: | ENSP00000426330 ⟸ ENST00000509576 |
Ensembl Acc Id: | ENSP00000486367 ⟸ ENST00000629036 |
Ensembl Acc Id: | ENSP00000427082 ⟸ ENST00000510171 |
Ensembl Acc Id: | ENSP00000330349 ⟸ ENST00000330503 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q9UJV9-F1-model_v2 | AlphaFold | Q9UJV9 | 1-622 | view protein structure |
RGD ID: | 6802996 | ||||||||
Promoter ID: | HG_KWN:51922 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | Lymphoblastoid | ||||||||
Transcripts: | UC003MHM.1 | ||||||||
Position: |
|
RGD ID: | 6803005 | ||||||||
Promoter ID: | HG_KWN:51923 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | OTTHUMT00000253432, UC003MHN.1, UC003MHP.1, UC003MHQ.1 | ||||||||
Position: |
|
RGD ID: | 6852020 | ||||||||
Promoter ID: | EP73816 | ||||||||
Type: | multiple initiation site | ||||||||
Name: | HS_ABS | ||||||||
Description: | DEAD-box protein abstrakt. | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | NEDO full length human cDNA sequencing project.; Oligo-capping | ||||||||
Position: |
|
RGD ID: | 6871724 | ||||||||
Promoter ID: | EPDNEW_H9027 | ||||||||
Type: | initiation region | ||||||||
Name: | DDX41_1 | ||||||||
Description: | DEAD-box helicase 41 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:18674 | AgrOrtholog |
COSMIC | DDX41 | COSMIC |
Ensembl Genes | ENSG00000183258 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000330503 | ENTREZGENE |
ENST00000330503.12 | UniProtKB/Swiss-Prot | |
ENST00000503078 | ENTREZGENE | |
ENST00000504781.5 | UniProtKB/TrEMBL | |
ENST00000507955.6 | UniProtKB/TrEMBL | |
ENST00000508279.5 | UniProtKB/TrEMBL | |
ENST00000509576.5 | UniProtKB/TrEMBL | |
ENST00000510171.3 | UniProtKB/TrEMBL | |
ENST00000625286.1 | UniProtKB/TrEMBL | |
ENST00000629036.2 | UniProtKB/TrEMBL | |
Gene3D-CATH | 3.40.50.300 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GTEx | ENSG00000183258 | GTEx |
HGNC ID | HGNC:18674 | ENTREZGENE |
Human Proteome Map | DDX41 | Human Proteome Map |
InterPro | DEAD/DEAH_box_helicase_dom | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
DEADc_DDX41 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Helicase_ATP-bd | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Helicase_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
P-loop_NTPase | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
RNA_helicase_DEAD_Q_motif | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
KEGG Report | hsa:51428 | UniProtKB/Swiss-Prot |
NCBI Gene | 51428 | ENTREZGENE |
OMIM | 608170 | OMIM |
PANTHER | ATP-DEPENDENT RNA HELICASE DBP3 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
ATP-DEPENDENT RNA HELICASE DDX41-RELATED | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | DEAD | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Helicase_C | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
PharmGKB | PA134908862 | PharmGKB |
PROSITE | HELICASE_ATP_BIND_1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
HELICASE_CTER | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Q_MOTIF | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
SMART | DEXDc | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
HELICc | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Superfamily-SCOP | SSF52540 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A499FJW5_HUMAN | UniProtKB/TrEMBL |
B2RDC8 | ENTREZGENE | |
B3KRK2 | ENTREZGENE, UniProtKB/TrEMBL | |
D6RD33_HUMAN | UniProtKB/TrEMBL | |
D6RGI7_HUMAN | UniProtKB/TrEMBL | |
DDX41_HUMAN | UniProtKB/Swiss-Prot | |
H0Y8L8_HUMAN | UniProtKB/TrEMBL | |
H0YA06_HUMAN | UniProtKB/TrEMBL | |
Q53HI2 | ENTREZGENE, UniProtKB/TrEMBL | |
Q96BK6 | ENTREZGENE | |
Q96K05 | ENTREZGENE | |
Q9NT96 | ENTREZGENE | |
Q9NW04 | ENTREZGENE | |
Q9UJV9 | ENTREZGENE | |
UniProt Secondary | B2RDC8 | UniProtKB/Swiss-Prot |
Q96BK6 | UniProtKB/Swiss-Prot | |
Q96K05 | UniProtKB/Swiss-Prot | |
Q9NT96 | UniProtKB/Swiss-Prot | |
Q9NW04 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-01-12 | DDX41 | DEAD-box helicase 41 | DDX41 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 | Symbol and/or name change | 5135510 | APPROVED |